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ABSTRACT OF THE DISSERTATION
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The manipulation of cellular state has many promising applications, including stem cell biology
and regenerative medicine, biofuel production, and stress resistant crop development. The
construction of interaction maps promises to enhance our ability to engineer cellular behavior.
Within the last 15 years, many methods have been developed to infer the structure of the gene
regulatory interaction map from gene abundance snapshots provided by high-throughput
experimental data. However, relatively little research has focused on using gene regulatory
network models for the prediction and manipulation of cellular behavior. This dissertation
examines and applies strategies to utilize the predictive power of gene network models to guide
experimentation and engineering efforts. First, we developed methods to improve gene network
models by integrating interaction evidence sources, in order to utilize the full predictive power of
the models. Next, we explored the power of networks models to guide experimental efforts
through inference and analysis of a regulatory network in the pathogenic fungus Cryptococcus
neoformans. Finally, we develop a novel, network-guided algorithm to select genetic
interventions for engineering transcriptional state. We apply this method to select intervention
strains for improving biofuel production in a mixed glucose-xylose environment. The
contributions in this dissertation provide the first thorough examination, systematic application,
and quantitative evaluation of the utilization of network models for guiding cellular engineering.

xi

Chapter 1: Introduction
A paradigm shift has occurred in biological research in the past 15 years, from the study
of only a small number of genes at a time, to the system wide study of molecular interactions in a
cell. This rapidly expanding field of Systems Biology focuses on understanding cellular
processes by mapping and modeling the cellular interactome. The construction of interaction
maps promises to enable us to predict and manipulate cellular behavior, which will have many
important applications such as human disease treatment and stress resistant crop development.
Determining the transcriptional regulatory relationships between transcription factors and their
target genes, which control the abundance of each gene product, is a key step towards gaining a
complete view of the cell’s interactome.
Gene expression profiles, or RNA profiles, yield quantitative data on the transcriptional state of a
cell in a specific condition and time. Recent advances in high throughput methods for characterizing gene
expression, such as DNA microarrays and RNA-seq, have made it easier, cheaper, and faster to obtain
gene expression profiles. These experimental advances have spurred the development of computational
methods that use gene expression profiles to infer a model of the global transcriptional regulatory
network. In the last decade many algorithms have been developed to infer the structure of gene

regulatory networks from gene expression profiles. A common approach taken by these
algorithms to learning transcriptional regulatory network structure is to find, for each gene ga,
another gene or group of genes encoding transcription factors whose RNA levels best explains
ga's RNA level. As more sophisticated methods have been developed, the structural accuracy of
inference algorithms has dramatically improved. Despite the advances in structural network
recovery, transcriptional network inference has not met the need to generate predictive models
that aid in experimental design and cellular engineering efforts.
1

Understanding, predicting, and manipulating complex cellular states requires structural
and functional models of the cell. Most gene regulatory network inference algorithms provide a
structural map of transcriptional interactions and an underlying mathematical model that can
predict transcriptional results of genetic interventions. However, research using network models
generally focuses on interpretation of the network structure, and neglects to use networks models
to predict expression and physiological phenotypes. This dissertation begins to bridge the gap
between inferring gene regulatory network models and utilizing the predictive power of the
models to guide further research. First, we integrate the processes of inferring gene regulatory
network models and de novo inference of transcription factor binding specificity to generate a
causative, as opposed to a correlative network model, while exploring the ability of network
models to aid in identifying transcription factor binding sites. We then explore the ability of
network models to guide research by taking an active learning approach, which iterates between
network inference and physiological phenotype prediction. Finally, we demonstrate the ability of
causative regulatory network models to guide a cellular engineering effort by generating strains
with regulatory interventions selected by simulated intervention expression predictions.
In chapter 2, we investigate strategies to infer more causative network models consisting
of interactions that are supported by direct and functional evidence. Causative network models
allow for better network-based expression and phenotype prediction than network models that
rely solely on correlative analysis because they eliminate the effects of indirect regulatory
interactions. To respond to the need for more causative network models for prediction
applications, we develop a method to integrate the processes of network inference from gene
expression profiles and de novo TF binding motif discovery. Through iteration, we are able to
identify novel TF binding motifs and integrate them into the network to enrich the network for
2

direct causative interactions. We evaluate this approach by applying it to the inference of the
Saccharomyces cerevisiae and Cryptococcus neoformans networks and TF binding motifs. In
Cryptococcus neoformans, we identify 18 TF binding motifs, 15 of which are novel.
In chapter 3, we map and model a regulatory network in Cryptococcus neoformans
controlling the size of the fungal pathogen’s capsule by joining the processes of computational
modeling and experimentation. In this project, we explore the utility of network models as
guidance for selecting costly experiments, by iterating between inferring the transcriptional
regulatory network, using the network to make physiological phenotype predictions and selecting
the next expression profiles to acquire. During this process we identify 18 novel regulators
controlling the size of the polysaccharide capsule, which increased the number of known capsule
size regulators to 27. With the finalized network map, we are able to identify many regulators
controlling the enzymes responsible for the creation of capsule sugars.
Finally, in chapter 4, we fully evaluate the predictive power of causative network models
by using a network model to guide transcriptome engineering. In this work, we build on our
successes and knowledge gained in constructing and utilizing causative networks for prediction
to develop the first validated, network-guided algorithm to select interventions for engineering
transcriptional state. The NetSurgeon algorithm simulates regulator deletion and overexpression
interventions on a causative network model, and selects the interventions that are predicted to
force the expression state toward a goal state. We apply this algorithm to select intervention
strains yielding promising results for improved biofuel production in a mixed glucose-xylose
environment which have an enhanced fermentative transcriptional state in glucose-limited
conditions. In addition, our generated intervention strains included strains with 120% higher
xylose import rates and 31% increased ethanol production rates. The transcriptional and
3

metabolic enhanced fermentative state of these strains demonstrates the power of using causative
networks models to guide cellular engineering.

1.1 Contributions
1. Development of methods to remove indirect regulatory network edges by inferring
and integrating transcription factor binding specificity. We present a method for de
novo transcription factor binding motif inference by utilizing regulatory network structure
and DNA-binding domain similarity. This contribution is presented in chapter 2.
2. Inference and analysis of the Cryptococcus capsule regulatory network. We take a
network-driven iterative approach to infer the network that regulates the production and
thickness of the polysaccharide capsule of Cryptococcus neoformans, the key virulence
factor of this pathogenic fungus. This contribution is presented in chapter 3.
3. Development of NetSurgeon, a novel algorithm for regulatory intervention selection.
We present an algorithm which aids in the rational manipulation of transcriptomes by
utilizing a regulatory network to identify overexpression and deletion interventions that
will force the expression state towards a desired goal state. This contribution is presented
in chapter 4.
4. Application of NetSurgeon to engineer Saccharomyces cerevisiae strains. We apply
NetSurgeon to Saccharomyces cerevisiae biofuel production, by selecting and generating
intervention strains that promote a fermentative transcriptional state in the presence of
xylose, an alternative carbon source. This contribution is presented in chapter 4.

4

Chapter 2:
Integration of Transcription Factor Binding
Specificity
2.1 Abstract
Gene network models are vital to understanding how genes interact to regulate the
transcriptional response to external stimuli. Within the last 15 years, much research has focused
on inferring the structure of the gene regulatory networks. There have been two distinct
approaches to this problem: regulatory network model inference from gene expression profiles
and regulatory network model construction from identified transcription factor binding sites. In
this work we have developed methods to integrate these approaches. We show that the gene
regulatory network model structure can be improved by integrating known or inferred
transcription factor binding specificities. We also demonstrate methods to improve DNA binding
specificity inference, and we apply these methods to infer PWMs for C. neoformans transcription
factors. Our application of these methods increased the number C. neoformans transcription
factors with known binding specificities from 2 to 18.

2.2 Background
2.2.1 DNA Motif Discovery
One approach for constructing gene regulatory network models is to utilize the DNA
binding specificities of transcription factors (TFs) to identify binding sites in the promoters of
5

target genes. The binding specificity of a TF can be represented as a position weight matrix
(PWM), which gives the probability of observing nucleotide j in position w of bound sequences.
A score for an aligned substring can be calculated as the sum of log-likelihoods at each position
of the alignment. By scoring substrings of DNA, PWMs can be used to identify sites with a
greater potential for TF binding and transcriptional regulation.
There is a rich literature of computational methods for de novo DNA binding motif
discovery. These methods identify similar DNA motifs within multiple input DNA sequences.
DNA binding motif discovery methods are often used to infer TF binding specificity models by
searching through TF bound promoters to identify enriched motifs. There are two broad
approaches taken by these methods: mixture-modeling and discrimination (Lee et al. 2013).
Many mixture model based methods use either expectation maximization (example: MEME,
Bailey et al. 2006), or Gibbs Sampling (example: BioProspector, Liu et al. 2001) to identify TF
binding sites and estimate PWMs. Discriminatory approaches, including CMF (Lee et al. 2013)
and FIRE (Elemento et al. 2007), identify motifs that maximally separate a set of bound and
unbound sequences. The identification of TF binding sites has been a major area of biological
research and many current algorithms have been successfully demonstrated in lower model
organisms (Das et al. 2007). However, computational motif discovery remains a challenging
problem, beset with high false positive rates, and in need of additional prior knowledge to aid
motif discovery (Simcha et al. 2012).
In recent years, the identification of transcription factor binding sites (TFBS) has
improved dramatically through in vivo (ChIP) and in vitro (e.g. protein-binding microarray,
PBM) methods for measuring protein DNA binding (Valouev et al. 2008 & Berger et al. 2009).
There have been several large studies using these experimental techniques (Harbison et al. 2004;
6

Lee et al. 2002; Nègre et al. 2011; Badis et al. 2009; ENCODE Project Consortium 2012;
Weirauch et al. 2014) and PWMs inferred in these studies are available in many public databases
(Spivak & Stormo 2012; Shazman et al. 2013; Bryne et al. 2008; Matys et al. 2003).
The large-scale availability of TF binding specificity models has allowed researchers to
identify links between protein homology and DNA binding specificity. Specifically, with the
advent of large collections of inferred PWMs, several groups have conclusively shown that TFs
with similar DNA binding domains (DBDs) also have similar TF binding specificities (Weirauch
et al. 2014; Jolma et al. 2013). This observation was used by the Hughes group in their Cis-BP
database of TF binding specificities (Weirauch et al. 2014). In the Cis-BP database they infer
binding specificities for TFs without experimentally derived PWMs by assigning the PWM of
the TF with the most similar DBD. Several other approaches have used machine learning
techniques, including K-Nearest-Neighbors and Random Forests, to predict binding specificities
for TFs from the PWMs of homologous TFs (Gupta et al. 2014; Christensen et al. 2012).
There has been a rapid rise in the number of TFs with known or inferred binding
specificities. However, there is not a reliable binding specificity model for most non-model
organism TFs (Weirauch et al. 2014). Even for human TFs, only 974 of the 1,734 putative TFs
have a binding specificity model that has been experimentally derived or inferred (Weirauch et
al. 2014). Therefore, to avoid costly experimentation, additional research is required to improve
computational motif inference.

2.2.2 Gene Expression-Only Approaches for Inferring Gene Regulatory
Networks
Another approach for constructing gene regulatory network models involves inferring the
models from gene expression profiles. Advances in high throughput methods for characterizing
7

gene expression have spurred the development of computational methods aimed at inferring the
structure and kinetics of regulatory networks (Gardner & Faith 2005). These algorithms attempt
to learn a network that best explains the measurements of all RNA transcripts in cells grown
under various experimental conditions.
To evaluate the structural accuracy of an inferred network model, predicted interactions
are ranked by confidence scores and compared to the true network structure, which is typically
defined by ChIP-seq and ChIP-chip experiments that identify transcription factor binding sites on
the promoter of target genes. A series of predicted networks is constructed by going down the list
of predicted interactions, from most confident to least confident, and adding one interaction at a
time to the previous network in the series. Each of these networks is evaluated using precision
and recall statistics, which measure the accuracy and completeness of the inferred networks,
respectively.
The most accurate and most recent expression only network inference algorithm is
NetProphet (Haynes et al. 2013). This algorithm achieves superior accuracy by analyzing the
expression profiles in two ways, then combining the results into a single model. First,
NetProphet uses a LASSO solver to infer a regression-based regulatory network. In addition,
NetProphet constructs a perturbation-based regulatory network by inferring interactions between
experimentally perturbed regulators and the genes that are significantly affected by each
perturbation. These two regulatory networks are weighted and combined. This approach has been
demonstrated to be the best expression-only method for inferring the gene regulatory network
structure of S. cerevisiae.
Although expression-only methods have improved dramatically, these algorithms are
only able to infer a portion of the S. cerevisiae regulatory network with convincing accuracy.
8

Several challenges must be addressed in order to improve accuracy. First, expression-only
inference methods rely upon co-expression of transcription factors and target genes to recover
interactions. This reliance on co-expression allows these methods to recover many direct
functional interactions; however, these methods can also incorrectly infer interactions between
TFs and target genes that are indirectly co-expressed. A second challenge faced by these
inference methods is modeling combinatorial gene regulation. Instead of direct transcriptional
control by a single regulator, the transcription of many targets is controlled by the combined
effects of several regulators. Combinatorial regulation makes it more difficult to infer true
regulators by obscuring the relationship between regulator and target RNA concentration.

2.3 Related Work
Network inference approaches which utilize both expression-based inference and
transcription factor binding site knowledge are strengthened by prioritizing interactions that the
two approaches support. Support from each approach provides physical evidence of protein
DNA binding and functional evidence of a regulatory effect. There are several notable methods
which utilize this integrative network inference approach.
In recent work, Marbach et al. used an integrative approach to construct a gene regulatory
network for D. melanogaster (Marbach et al. 2012). They constructed one network from
interactions supported by ChIP experiments and TF binding motifs. They then constructed a
second network from functional evidence by correlating expression patterns of transcription
factors and target genes. Finally, they averaged the interaction scores from the functional and
physical networks. Interestingly, although the physical and functional networks show little

9

overlap in their most confident interactions, Marbach et al. found that averaging the two
evidence sources generated a more accurate network.
A few methods have been proposed to integrate physical evidence directly into the
regression approach for inferring gene regulatory networks. One notable example is the TILAR
method, which uses knowledge of transcription factor binding sites to modify the L1 LASSO
penalty (Hecker, Goertsches, Engelmann, Thiesen, & Guthke, 2009). This modification
influences the order of regulator selection for each gene by biasing the selection toward
regulators that are supported by prior knowledge.
Integrative network inference methods are often able infer regulatory networks with more
accuracy than expression-only inference methods (De Smet et al. 2010). Moreover, the
integration of binding data helps to solve some of the common problems encountered by
expression-only inference methods, as binding data can be used to filter-out indirect regulatory
interactions. Although integrative approaches are extremely promising, current approaches are
stifled by their reliance upon prior knowledge of TF binding specificity. Due to the
incompleteness of TF binding specificity knowledge, even for well studied organisms,
integrative approaches must be able to infer novel TF binding specificities to reach their full
potential.

2.4 Approach
In this work we investigated strategies to generate more accurate gene regulatory network
models by integrating the processes of expression-only network inference and de novo DNA
binding motif discovery. Our approach to integrating these processes started by using NetProphet
(Haynes et al. 2013) to infer a gene regulatory network model from gene expression data (Fig 2.1
Top). Next, we inferred the DNA binding specificity of each TF by searching for enriched motifs
10

in the promoters of high confidence targets of the each TF (Fig 2.1 Middle). Finally, we
integrated inferred DNA binding specificities into the gene regulatory network model by
combining the functional network interaction scores assigned by NetProphet with the physical
network interaction scores assigned by scanning the PWMs over all promoter sequences (Fig 2.1
Bottom).

Figure 2.1. Integrated regulatory network and DNA binding specificity inference. Top: Inference of a gene
regulatory network model from gene expression profiles. Middle: Inference of DNA binding specificity of each TF
from the promoter sequences of the predicted targets of the TF. Bottom: Modification of interaction confidence
scores in the network model using inferred DNA binding specificity.

2.5 Results
2.5.1 Integration of known TF DNA binding specificities improves structural
accuracy
To assess the improvements to the gene regulatory network model by integrating TF
binding specificities, we constructed an integrated functional and physical network of S.
cerevisiae. The integrated network model was constructed by combining the original published
11

NetProphet network model produced by Haynes et al. (Haynes et al. 2012) with a regulatory
network constructed by scanning all known S. cerevisiae PWMs (Spivak & Stormo, 2012) over
all promoter sequences. Finally, the integrated NetProphet+PWM network model was
constructed by computing the geometric mean of scores in the functional and physical networks.
We evaluated the structural accuracy of the NetProphet+PWM network and compared it
to the accuracy of the separate NetProphet and PWM networks. The gold standard was a network
of over 29,000 chromatin immunoprecipitation (ChIP) implicated interactions (Abdulrehman, et
al. 2010; Balaji et al. 2006; Harbison et al. 2004; Lee et al. 2002). We plotted a precision-recall
curve for each network (Fig 2.2).

Figure 2.2. Integration of DNA binding specificity improves network structure. Precision-Recall plot showing the
recovery of ChIP-supported interactions by the NetProphet inferred network (purple), binding potential network
constructed using ScerTF binding models (Yellow), and a network constructed by combining NetProphet and the
binding potential network (green). Random ChIP recovery is shown by the gray dotted line.

We examined the ChIP support of the most confident predicted interactions of each
network by focusing on the initial 5% of the recall space. Throughout this recall space the
NetProphet+PWM (Fig 2.2, Green) network integration curve dominated the NetProphet (Fig
12

2.2, Purple) and PWM binding specificity based (Fig 2.2, Yellow) network curves. We computed
the area under the precision-recall curve (AUPRC) and found that the AUPRC for the
NetProphet+PWM curve is 1.8 fold and 1.4 fold greater than the NetProphet and PWM network
AUPRCs, respectively. Importantly, we have observed similar integrated network improvements
when using a functional network inferred from a different large-scale gene deletion expression
dataset (Kemmeren et al. 2014), and when using a physical network constructed from proteinbinding microarray (PBM) obtained PWMs (data not shown), indicating that integrating TF
DNA binding specificities should generally improve network models.

2.5.2 Distinguishing good from bad binding specificity models
Inspired by the observed improvements gained by combining functional and physical
networks, we decided to integrate the processes of gene regulatory network inference and de
novo DNA binding motif discovery. Performing de novo DNA binding motif discovery will
allow us infer novel TF binding specificities and expand integrative network improvements
beyond the confines of experimentally derived PWMs. Since computational motif discovery has
high false positive rates, novel methods were required to select only accurate PWM models of
TF binding specificity. Without the ability to distinguish accurate from inaccurate PWMs,
integration of DNA binding specificities into an integrative network model would likely decrease
model quality.
To identify accurate PWMs for each TF, we compared the target rankings produced by
the PWM models with the target rankings produced by NetProphet. Similar to a published
approach which links motifs to TFs (Verfaillie et al. 2014), we hypothesized that target gene
rankings from an accurate PWM for a TF will agree with the NetProphet target rankings for the
TF significantly better than target rankings produced by random PWMs. We investigated many
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potential metrics to measure the relationship between the NetProphet target rankings and PWM
based target rankings. We computed the similarity between the rankings by correlation (Pearson,
Spearman, and Kendall), and mutual information. We separated the NetProphet targets into two
binary sets of bound and unbound targets, and compared the PWM-based ranking of targets to
these categorical sets using AUPRC and Fisher’s exact test. Also, we fit a linear regression
model to explain target gene expression form PWM scored binding potential. We used the
magnitude of the regression coefficient as a final measure of the PWMs accuracy.
To evaluate these metrics, we used each one to score the relationship between the
NetProphet target set rankings of each TF and the target rankings produced by scanning the
ScerTF PWM of each TF. For each PWM, we standardized the PWM’s relationship score
(converted to Z-scores) with each NetProphet target set. Then, we assessed the degree to which
higher scores were assigned when the NetProphet and PWM target set rankings were generated
for the same TF, rather than different TFs. We plotted the mean Z-scores of target set rankings
generated for the same TF (Fig 2.3). We found that using Pearson correlation, Fisher’s exact test,
and the magnitude of the regression coefficient explaining gene expression from binding motifs
were significantly better than other metrics at matching each NetProphet target set with the
correct PWM. We decided to use the Pearson correlation coefficient for subsequent analysis due
to its ease of use, and computational speed.
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Figure 2.3. Investigation of methods to identify good binding specificity models. Barplot showing the ability of
different metrics to identify the binding specificity model of each TF. The mean of the z-scores assigned to the true
binding specificity models is plotted for each metric.

2.5.3 Integration of Network and DNA Binding Specificity Inference
With metrics capable of selecting accurate PWMs by comparing PWM based ranking of
target genes to NetProphet ranking of target genes, we refocused on integrating de novo inferred
PWMs into a network model. We used the NetProphet network as our functional network. We
used COSMO (Bembom et al. 2007), a MEME-type motif finder, for PWM inference. In total
we discovered five potentially different PWMs for each TF by inferring a single PWM for each
of 5 expression pattern based clusters of NetProphet predicted targets. We assigned confidence
scores to each PWM by utilizing our method to distinguish good from bad binding specificity
models. Specifically, the confidence score for each PWM was the Z-score of Pearson correlation
coefficient of the target set rankings produced by the PWM and matching NetProphet target set.
For each TF we scanned all 5 PWMs over target promoter sequences and combined scores by
weighted averaging, with each PWM’s confidence score serving as its weight. We then
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constructed an integrated network by computing the geometric mean of scores in the functional
and physical networks. To evaluate the integrated network, we plotted precision and recall of the
NetProphet network (Fig 2.4.A, Purple), inferred PWM based network (Fig 2.4.A, Yellow), and
the NetProphet + inferred PWM network (Fig 2.4.A Green).

Figure 2.4.A. Precision recall curves showing the recovery of ChIP-supported interactions by the NetProphet
network (purple), binding potential network constructed from inferred binding models (Yellow), and integrated
network (green). Random ChIP recovery is shown by the gray dotted line.

The integrative network had an AUPRC that was 1.3 fold greater than the NetProphet
alone. Interestingly, this improvement occurs even though the physical network constructed
using inferred PWMs (AUPRC: 0.1) is much less accurate than the physical network constructed
using known PWMs (AUPRC: 0.19).
Next, we evaluated the accuracy of the inferred PWMs. We focused on a set of 187
inferred PWMs of TFs that have a known PWM (Spivak & Stormo 2012). Our correlative
method for assigning confidence scores to inferred PWMs classified 38 as strong (Bonferroni
corrected P-value <= 0.01), 25 as medium (Bonferroni corrected P-value between 0.01 and 0.2),
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and 124 as weak (Bonferroni corrected P-value > 0.2). We evaluated these confidence
classifications by comparing the classifications to the accuracy of the inferred PWMs by aligning
the inferred PWMs with the true PWMs (Fig 2.4.B). We found that inferred PWMs in the strong
confidence bin aligned better with their matching known PWMs then the PWMs in either the
medium (Mann-Whitney U test p-value < 0.05) or weak bins (Mann-Whitney U test p-value <
10-4).

Figure 2.4.B. Accuracy of inferred PWMs is predicted by their confidence scores. Barplot showing the mean
significance of inferred PWMs aligned with their matched known PWM. The inferred PWMs were binned by the
confidence score of the inferred PWM. Turquoise: High confidence, Red: Medium confidence, Blue, low confidence

2.5.4 Improving DNA Binding Specificity Inference
Although we were able to improve the structural accuracy of the inferred network by
integrating inferred PWMs, we were only able to infer high confidence PWMs for 38 of the 187
S. cerevisiae TFs. In order to approach the network model improvements demonstrated for
known PWMs, we must do better. Therefore, we investigated strategies to improve PWM
inference.
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Many TFs are enriched to either up-regulate or down-regulate their direct targets, and
these TFs are classified as activators or repressors respectively (Kemmeren et al. 2014).
Activator/Repressor classification knowledge can benefit both motif discovery and network
inference by modifying the confidence in each TF-target interaction based on a comparison of
the expected and observed effect of the TF on the target. However, these classifications do not
exist for many less well-studied organisms. Therefore, instead of using the TF classifications
directly, we used the existence of these TF classifications as motivation for performing DNA
motif discovery separately on the activated and repressed targets of each TF. As an initial
validation of this approach, we binned NetProphet predicted targets of the C. neoformans TF
Usv101 (Fig 2.5.A, Top) by their confidence score and regulatory sign (activated/repressed by
Usv101), and identified the bins that are enriched with Usv101 motif hits (Fig 2.5.A, Bottom).
We found that the most confidently repressed targets of Usv101 (top left bins) were also the bins
most enriched for Usv101 motif occurrences (bottom left bins shaded red). Further, the motif
recovered from the repressed targets of Usv101 was confirmed by ChIP experiments (Figure
3.6.D).

Figure 2.5.A. Interaction signs aid in DNA binding motif discovery. Top row: The targets of Usv101, a C.
neoformans TF, binned by NetProphet confidence and predicted regulatory sign (activation or repression). Bottom
row: Heatmap of occurrences of the Usv101 DNA binding motif in the promoter region of the binned genes. Red
shading indicates more occurrences of the motif, blue indicates fewer.
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We also investigated a second approach to improve binding specificity inference which
was motivated by the observation that TFs with similar DBDs also tend to have similar PWMs
(Weirauch et al. 2014; Jolma et al. 2013). To evaluate this observation in S. cerevisiae we
computed the DBD homology and PWM similarity for all pairs of TFs. DBD homology was
computed using BLASTP (Altschul et al. 2007) and PWM similarity was computed using
TOMTOM (Gupta et al. 2007). For each DBD homology significance threshold, from an E-value
of 1 to an E-value of 10-30, we plotted the fraction of DBD homologous TFs that also have
similar PWMs (Fig 2.5.B). Confirming previous publications (Weirauch et al. 2014; Jolma et al.
2013), we observed a logistic trend in which more homologous DBDs were more likely to have
similar PWMs.

Figure 2.5.B. Relationship between DBD homology and PWM similarity for S. cerevisiae TFs. DBDs of all pairs of
S. cerevisiae TFs were aligned and for each bin of DBD homology, computed as –log10 E-value), the fraction of TF
pairs with similar PWMs was plotted (PWM alignment E-value < 1).

We utilized this relationship between DBD homology and PWM similarity to improve
PWM inference by computing a weighted average of NetProphet target confidence scores for
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TFs with similar DBDs. By taking the weighted average of NetProphet target confidence scores,
the top NetProphet targets for a TF will be targets that are shared by multiple TFs with similar
PWMs, enriching the top targets for genes that have the right binding motif family in their
promoters. Weights were assigned to each TF’s NetProphet target set fitting a logistic curve to
the relationship between DBD homology and PWM similarity (Figure 2.5.B). Therefore, to
generate DBD modified NetProphet target set confidence scores for a TF, the TF’s target set
confidence scores were given a weight of 1 and combined with other target set confidence scores
for TFs that have similar DBDs (E-value < 10-10), each weighted by their DBD similarity to the
original TF.
Next we performed DNA motif discovery using the DBD modified NetProphet target
confidence scores. The motif finding tool FIRE was used to identify sequence-specific binding
motifs (Elemento et al. 2007). FIRE identifies a set of 7-mers, that can be converted to a PWM,
whose presence or absence in a given regulatory region share strong mutual information with
functional information about the corresponding genes (e.g. gene expression). In this case, the
functional information used were the DBD modified NetProphet target confidence scores. We
used FIRE to discover DNA motifs in S. cerevisiae and C. neoformans. For each of these
organisms we counted the number of motifs FIRE discovers through mutual information with
original NetProphet confidence scores, signed confidence scores, DBD modified confidence
scores, and signed DBD modified confidence scores (Fig 2.5.C). We found that FIRE discovered
an average of 2.7 fold and 1.8 fold more motifs when using the signed NetProphet scores and
DBD NetProphet scores respectively compared to using the original NetProphet scores. In
addition, using both sign and DBD homology information together allowed FIRE to recover the
most motifs, an average of 3.7 fold more motifs than using the original NetProphet scores.
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Figure 2.5.C. DBD homology and interaction sign aid DNA binding specificity inference. Barplot showing the
number of DNA binding motifs inferred by FIRE when using each of four different networks. The number of motifs
is displayed for S. cerevisiae (turquoise) and C. neoformans (red).

2.5.5 Inference of DNA Binding Specificities in C. neoformans
Although we confirmed that using regulatory signs and DBD homology allowed us to
recover more PWMs, the accuracy of the inferred PWMs must still be assessed. We evaluated
the correctness of each inferred C. neoformans motif using several metrics including FIRE
reported motif confidence scores, motif occurrence conservation in C. neoformans JEC21, and
PWM similarity for DBD homologous S. cerevisiae TFs. Using these evaluation metrics, we
separated inferred motifs into three confidence bins (Fig 2.6). The first bin consisted of the three
ChIP motifs inferred using BioProspector on the ChIP defined target sets of Gat201, Nrg1, and
Usv101. The second and third bins consist of high and medium confidence motifs inferred using
FIRE with the signed DBD modified NetProphet predicted target sets. The high and medium
confidence motif sets both passed all initial evaluation criteria; however, the high confidence
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motif set had better agreement with the NetProphet predicted target scores than the medium
motif confidence set. In total, the PWMs increased the number of C. neoformans TFs with
known binding specificities from 2 to 18. In addition, for each TF with a motif, the regulatory
role of the TF (activator / repressor / both) was assessed by comparing the enrichment of
activated and repressed targets with likely bound targets.

Figure 2.6. Logos representing the DNA binding specificities of 18 Cryptococcus TFs with supporting evidence.
The three logos at the top of the left column were inferred from ChIP data using BioProspector and the remaining 15
were inferred from NetProphet scores using FIRE. Cneo TF: Cryptococcus TF identifiers and inferred function as
activator, repressor, both, or unknown. Motif: logos. Scores: Our overall confidence in the accuracy of the motif
followed by the mutual information Z-score from FIRE, the robustness score from FIRE, and whether the motif was
highly conserved in the promoters of genes in Cryptococcus serotype D strain JEC21 that are orthologs of the targets
of the indicated KN99 TF. Motif align: List of S. cerevisiae TFs whose motifs in the ScerTF database show the
strongest resemblance to the inferred motif for the indicated Cryptococcus TF. S. cerevisiae TFs are listed in order
of similarity, starting with the TF that is most similar and ending with the supporting ortholog chosen on the basis of
similar DNA binding domain (DBD) and similar sequence specificity. For each S. cerevisiae TF, E-value output by
TOMTOM for the alignment of its motif to that of the indicated C. neoformans TF is shown. The best possible
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support for the assignment of a motif to a C. neoformans TF is an S. cerevisiae TF with a highly similar DBD that
also has highly similar sequence specificity (e.g. Nrg1, Usv101, Swi6, Cir1, Rim101, and Mbs1). DBD Align: S.
cerevisiae TFs listed in order of the similarity of their DBDs to the DBD of the indicated C. neoformans TF, ending
with the supporting ortholog chosen on the basis of similar DBD and similar sequence specificity. For each S.
cerevisiae TF, the percent protein identity of its DBD to that of the C. neoformans DBD is listed.

2.6 Discussion
In this chapter we’ve demonstrated that functional network models can be improved by
integrating physical TF binding data. We then showed that novel PWMs can be inferred de novo
from NetProphet rankings of targets, and that these novel PWMs can be used to improve the
network model structure. Finally, we investigated methods to improve de novo inference of DNA
binding specificities. We showed that NetProphet interaction confidence scores modified by
adding regulatory signs and utilizing DBD homology can improve the recovery of DNA binding
motifs. A clear next step for this work is to re-evaluate the structural improvement to the network
model by integrating inferred physical binding information (Appendix Figure 1).
In this chapter we only attempted a single round of gene network inference, de novo
DNA binding specificity inference, and model integration. However, we believe that these
inference steps could be continuously reapplied until no new PWMs are recovered. More
sophisticated methods for integrating PWMs into the network model would likely be required to
benefit from iterating these processes. Specifically, integrative approaches that modify the entire
network, not just the targets of the TFs with inferred PWMs are required so that the target sets of
TFs without a PWM are modified. A possible approach, similar to the TILAR method, would use
binding information to influence the regression based inferred network model through applying
adaptive weights to the L1 LASSO penalty (Zou 2006).
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2.7 Methods
2.7.1 Scanning PWMs and constructing a physical binding network
Each TF binding based network was constructed by using FIMO (Grant et al. 2011) to
scan PWMs over the 600 bases upstream of each gene’s transcription start site. Significant PWM
hits with P-value < 0.005 were used to score binding potential. For each TF, two models of
regulation were considered, a strong-site model in which target genes are scored based on the
maximum negative log P-value of significant PWM hits, and a weak-site model in which target
genes are scored based on the sum of the negative log P-values of significant PWM hits. The
strong and weak-site models were normalized on a per-TF basis so that the maximum target
binding score per-TF was 1. The final physical binding network was constructed by computing
the geometric mean of the strong and weak-site models of binding.

2.7.2 Combining functional and physical regulatory networks
To construct causative network models, the underlying functional and physical networks
were normalized so that the maximum interaction score for each model was 1 and combined by
computing the geometric mean of their scores.

2.7.3 Aligning PWMs
To assess the accuracy of inferred PWMs, we aligned the inferred PWMs against
a collection of known S. cerevisiae PWMs (Spivak & Stormo 2012) using TOMTOM (Gupta et
al. 2007). Inferred PWMs were considered accurate if they aligned well to the known correct
PWM or to another PWM for a TF with a similar DBD.
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2.7.4 Computing DBD homology
The DBD homology between pairs of TFs was computed by extracting the DBD of each
TF, then aligning the DBDs. The DBD portion of the protein sequences of every S. cerevisiae
(Engel, et al., 2014) and C. neoformans (Cryptococcus neoformans var. grubii H99 Sequencing
Project) TF was identified using the NCBI Conserved Domain Database search tool (MarchlerBauer et al. 2013). The DBD sequences of each TF were extracted and aligned to each other
using BLASTP (Altschul et al. 1997) version 2.2.29.

2.7.5 Evaluation of C. neoformans inferred PWMs
Several metrics were used to evaluate the correctness of each inferred motif. First, FIRE
performs extensive randomization tests to asses the relationship between the motif and functional
data. A cutoff of 8 was set on the FIRE reported Z-score of the MI value between the motif and
NetProphet target set, compared with random target sets. A cutoff of 7/10 was set on the FIRE
robustness score, which measures the robustness of the MI significance by 10 re-calculations of
MI after randomly removing one-third of the genes. Inferred motifs with scores below these
cutoffs were rejected. These cutoffs help ensure that inferred motifs were likely true functional
DNA recognition motifs for a TF in C. neoformans. Although conservation was not used as a
rejection criterion, the conservation of the motifs was also assessed using FIRE by comparing the
locations of motif occurrences in the promoters of C. neoformans H99 and C. neoformans
JEC21. Network-level conservation of each inferred motif was assessed and motifs with
conservation index >= 0.95 were defined as conserved. This index is the fraction of all possible
7-mers that are less conserved than the 7-mers permitted by the inferred motif. To also ensure
that the true functional motif is linked to the appropriate TF, the inferred motif was required to
align well (TOMTOM reported Q-value <= 0.5) to a known S. cerevisiae motif whose TF was
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required to share significant DBD homology (BLASTp E-value <= 1e-5) with the C. neoformans
TF of the aligning motif.

2.7.6 Inferring regulatory sign of C. neoformans TFs
To assign a regulatory role for each TF with an inferred PWM, the NetProphet-predicted
activated and repressed targets of the TF were compared to the targets predicted to be bound by
the TF (either by ChIP, or high scoring PWM hits). Only interactions in the top 20,000
NetProphet interactions were considered to identify activated and repressed targets of a TF. The
significance of binding of activated and repressed targets was computed in two ways. First, for
TFs with an inferred motif, a two-sample Mann-Whitney U test was used to assess the
significance of higher binding potential scores of activated (repressed) targets than the null
background of all other possible targets. Second, for TFs with ChIP evidence, a Hypergeometric
enrichment test was used to assign a P-value to the overlap between ChIP supported targets and
activated (repressed) targets. The P-values were adjusted using the Bonferroni correction. If a TF
had significant (p < 1e-3) enrichment for binding its activated (repressed) targets, then the TF
was defined as an activator (repressor). If a TF had significant enrichment for binding both its
activated and repressed targets, then the TF was defined as both an activator and a repressor. Any
TF without a significant (<1e-3) adjusted p-value was not assigned a regulatory sign.
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Chapter 3:
Model-driven mapping of transcriptional
networks
3.1 Abstract
Key steps in understanding a biological process include identifying genes that are
involved and determining how they are regulated. We developed a novel method for identifying
transcription factors (TFs) involved in a specific process and used it to map regulation of the key
virulence factor of a deadly fungus, its capsule. The map, built from expression profiles of 41 TF
mutants, includes 20 TFs not previously known to regulate virulence attributes. It also reveals a
hierarchy comprising executive, mid-level, and “foreman” TFs. When grouped by temporal
expression pattern, these TFs explain much of the transcriptional dynamics of capsule induction.
Phenotypic analysis of TF deletion mutants revealed complex relationships among virulence
factors and virulence in mice. These resources and analyses provide the first integrated, systems
level view of capsule regulation and biosynthesis. Our methods dramatically improve the
efficiency with which transcriptional networks can be analyzed, making genomic approaches
accessible to labs focused on specific physiological processes.

3.2 Background
In this work we present an efficient means of comprehensively mapping the network of
transcription factors (TFs) that regulate a particular physiological process. Our approach cycles
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through deletion of TFs, expression profiling of TF mutants, model construction, and modeldirected selection of TFs for the next round of deletion. This predictive genetics approach
identifies TFs that affect the process of interest, providing a valuable complement to undirected
mutagenesis and screening. Simultaneously, it builds a network model that explains how the TFs
affect the process, yielding novel insights into the biological system under study.
Mapping the network that regulates a specific process requires knowing which TFs affect
that process. One way to identify such TFs is to screen comprehensive mutant libraries, but
generating such libraries is not always feasible. Furthermore, genome-scale screening assays
must be fast and scalable; such assays may not exist for the process of interest or may be less
sensitive than other, more laborious assays. An alternative approach is to map the targets of all
TFs encoded in a genome by using methods such as chromatin- immunoprecipitation (ChIP) or
large-scale TF deletion and expression analysis. However, undirected, genome-wide approaches
are costly and inefficient for probing a specific biological process in detail. We report a modelguided approach that addresses all of these problems by focusing experimental effort on the TFs
most likely to be involved in the process of interest. Furthermore, our approach generates a
network that provides mechanistic explanations for the phenotypes of TF deletion mutants.
Our approach alternates network building by using an algorithm we call NetProphet with
identifying relevant TFs by using an algorithm we call PhenoProphet. NetProphet is a validated
method for mapping direct, functional regulation that significantly outperforms other network
mapping methods (Haynes et al. 2013). It requires only gene expression profiles of strains in
which TF expression has been perturbed (by gene deletion, mutation, overexpression, or RNAi)
and wild-type controls, data that can be gathered in a reliable, scalable way by most molecular
biology labs. It therefore offers significant advantages over alternatives such as ChIP-seq, which
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requires reoptimization for every TF studied (Landt et al. 2012) and follow-up experiments to
determine which binding events lead to functional regulation. NetProphet works by combining
differential expression (DE) analysis with co-expression analysis. In the DE analysis, genes that
are strongly differentially expressed between a TF-deletion strain and a wild- type (WT) strain
are considered potential targets of the TF. In the co-expression analysis, genes whose expression
is strongly correlated with that of a TF (either positively or negatively) across the expression
profiles are considered potential targets of the TF, enabling NetProphet to identify targets for
TFs that have not been directly perturbed (see Haynes et al. 2013). PhenoProphet, described here
for the first time, assigns each TF a score representing its confidence that deletion of that TF will
yield some phenotypic change of interest. The score of each TF is based on the degree to which
its NetProphet-predicted targets are enriched for genes associated with the phenotype of interest.
We demonstrate the power of combining NetProphet and PhenoProphet by mapping the
network that regulates the major virulence factor of a pathogenic yeast, Cryptococcus
neoformans. C. neoformans is a basidiomycetous yeast, with a 19 Mb genome encoding ~7000
genes (Janbon et al. 2014), that diverged from ascomycetes like S. cerevisiae roughly one billion
years ago (Hedges et al. 2004). It is also an opportunistic pathogen that is responsible for over
600,000 deaths per year worldwide (Park et al. 2009). Multiple factors influence cryptococcal
virulence (Srikanta et al. 2014), including the production of protective structures like melanin
and its major virulence factor, a polysaccharide capsule. Capsule polysaccharides are both
displayed on the cell surface and shed from the cell. The capsule grows large upon entry into a
mammalian host, a process that can be recapitulated by a variety of host-like conditions in vitro
(Zaragoza and Casadevall 2004).
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3.3 Related Work
The initial TFs implicated in regulating the virulence factors of C. neoformans are almost
uniformly major regulators of virulence which are directly downstream of the signaling
transduction pathways related to virulence factor induction conditions. The work which
identified these initial TFs relied upon protein conservation, genetic disruption, and microarray
based screening. For example, the iron responsive TF Cir1, which is required for virulence in a
mouse, was identified by searching the C. neoformans genome for an ortholog of the S.
cerevisiae iron regulators (Jung et al. 2006). In addition, Nrg1, a TF required for capsule
production and cell wall integrity, was identified through microarray analysis of cAMP activated
genes (Cramer et al. 2006). Although these studies identified many of the major virulence
regulators, new methods were required to expedite understanding by moving beyond the single
gene study approach.
One of the largest studies of this organism was a large-scale genetic screen which
identified dozens of previously uncharacterized genes that are linked with several assayed
virulence factors (Liu et al. 2008). For this genetic screen, a total of 1,201 gene knockout
mutants were generated and each mutant was screened for in vivo proliferation in murine lung
tissue, in vitro capsule formation, in vitro melanization, and growth at body temperature. Several
TFs important for regulating cryptococcal virulence factors were identified in this screen
including GAT201, a key regulator of virulence, which is required for proper induction of large
capsules and also regulates melanization.
Recent work on C. neoformans has started to incorporate Bioinformatics and Systems
Biology techniques to study the capsule virulence factor. Haynes et al. identified a set of 880
capsule signature genes whose expression significantly correlated with a capsule size in various
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conditions (Haynes et al. 2011). One of those genes was Ada2, a regulator of stress response
required for full induction of capsule. As a beginning step toward identifying the broader
network controlling capsule regulation, expression profiles of ada2, cir1 and nrg1 were used to
place Ada2 in a network model of capsule regulation.
Although several TFs involved in capsule regulation have been identified, however large
gaps remain in our understanding of capsule regulation (Rodrigues et al. 2011; O'Meara and
Alspaugh 2012; Kwon-Chung et al. 2014). Most of the downstream capsule biosynthetic
machinery remains to be discovered and current knowledge of capsule regulation is incomplete
and fragmented. This offers an ideal opportunity to apply model-guided network mapping. In
this work, we present the first integrated, systems level view of capsule regulation and
biosynthesis, which in turn produces unexpected insights into cryptococcal virulence.

3.4 Approach
We have developed a novel, predictive approach to identifying TFs related to a
physiological process of interest and mapping their regulatory targets. This approach consists of
a cycle (Fig. 3.1) in which TF deletion strains are subjected to phenotyping and expression
profiling and network models are constructed from the expression profiles by using NetProphet.
PhenoProphet is then used to predict additional TF genes which, when deleted, will influence the
process of interest. These genes are then deleted and the phenotypes and expression profiles of
the resulting mutants are fed back into the cycle. The genome-wide network models resulting
from this process can be analyzed in multiple ways, including modeling TF binding specificity
and predicting TF function based on target gene sets.
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Figure 3.1. NetProphet-PhenoProphet workflow. Yellow, steps involved in network modeling; blue, steps involved
in network refinement to elucidate a specific process of interest; green, products of genome-wide network analysis.

3.5 Results
3.5.1 Expression-based network mapping predicts TFs involved in capsule
regulation
We selected deletion strains to make and profile in several stages. First, we deleted genes
encoding 11 regulators previously reported to participate in capsule synthesis: 8 DNA-binding
TFs and 3 signaling proteins (Appendix Table 1, ‘Literature’). In the second stage, we deleted 17
genes encoding putative DNA binding proteins based on the correlation of their expression levels
with capsule size in various conditions (Haynes et al. 2011; Appendix Table 1, ‘Correlation’).
We grew these 28 deletion mutants and 3 others (Appendix Table 1, ‘Other’) in capsule-inducing
conditions and assayed them for capsule size. We developed custom software to facilitate precise
measurement of capsule thicknesses, enabling statistical analysis of thickness distributions. We
further subjected all of the mutant strains to expression profiling by RNA-seq in biological
triplicate after a shift to capsule- inducing conditions. We used the expression profiles of these
strains and WT controls as input for NetProphet to map the capsule regulation network (Fig. 3.1).
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To select the final group of genes to delete, we applied PhenoProphet to the NetProphetgenerated network along with 68 genes that have been reported to play a role in capsule
production (Appendix Table 2.A). These genes encode a variety of enzymes, transporters,
signaling factors, and proteins of unknown function. When we rank-ordered all TFs by their
PhenoProphet scores, we found that 14 of the 21 highest-scoring TFs had already been deleted;
12 of these 14 had altered capsule phenotypes. We deleted an additional 10 top-ranked TFs and
assayed their gene expression profiles and capsule sizes. Eight of these 10 had altered capsule
(80%). For comparison, a traditional screen of mutants that included 64 regulator deletions
identified only 3 required for normal capsule regulation (< 5%) (Liu et al. 2008).
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Figure 3.2. TF mutants have significant virulence-related phenotypes. For capsule the difference in thickness from
WT (in pixels) is tabulated and also color coded: green, a decrease of ≥10 pixels compared to wild type; blue, a
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decrease of 3-9 pixels; and yellow, an increase of ≥3 pixels. * denotes strains with WT mean capsule thickness but
significantly increased variance. For melanin formation, green indicates colonies that were white (no melanin) to
beige and blue indicates colonies that were brown but lighter than WT. For capsule shedding, green indicates that
the 3 hour culture supernatant concentration of GXM was ≥8-fold lower than WT; blue, 2-4-fold lower; yellow, 2fold higher. For short-term infectivity, fold-change in colony forming units (CFU) in 1 week was calculated (tested
only for strains with newly discovered capsule phenotypes). Green, >10 times lower than WT; blue, 2 to 10 times
lower; and yellow, > 2 times higher. In all columns gray indicates no significant change in phenotype.

Ten of our deletion strains had increased capsule thickness and 17 had reduced capsule
thickness (Fig. 3.2). Only 11 of the 27 had been previously reported to influence capsule
thickness. (The phenotype of cells lacking MBS1, which we studied because of its PhenoProphet
score, was reported while our analysis was in progress (Song et al. 2012).) Fig. 3.3.A shows the
altered capsule thicknesses of 17 mutants lacking TF-encoding genes that we selected based only
on expression data, analyzed by either capsule size correlation or PhenoProphet. Almost half of
our new mutants were hypercapsular, a phenotype that has been relatively rarely reported
(D'Souza et al. 2001; Bahn et al. 2005; Lee et al. 2009). Many of the mutants with altered
capsule size also showed significantly increased capsule size variability. Interestingly, two
mutants, ssn801 and clr2, showed a substantial increase in capsule size variability (2.9-fold,
p<10-78 and 1.6-fold, p<10-18, respectively) with no change in mean capsule size.
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Figure 3.3.A. Capsule thicknesses of 17 novel altered capsule mutants. Representative cells of our new mutant
strains, selected so all have similar cell wall diameter and each has capsule thickness very close to the average
determined for that mutant. Images are all to the same scale (bar = 5 microns) and ordered by capsule size. Colors
indicate capsule size groups as in Fig. 3.2.

We also assessed other virulence-related phenotypes in our uniform collection of 41
mutants. In addition to displaying capsule polysaccharide on its surface, C. neoformans sheds
this material into the environment, with adverse effects on the host immune response (Coelho et
al. 2014). We used a cryptococcal antigen latex agglutination test to assess capsule shedding in
our strain set. Interestingly, both hyper- and hypocapsular strains showed alterations in capsule
shedding (Fig. 3.2). Many of our new mutants also had defects in melanin production, a
virulence factor (Eisenman and Casadevall 2012) (Fig. 3.2). Finally, we tested our new mutants
for their ability to grow in the mouse lung; 11 showed a significant change in this characteristic
(Fig. 3.3.B).

Figure 3.3.B. Mouse lung growth of 17 novel altered capsule mutants. Mean ± SEM of infectivity results; the
horizontal gray bar denotes fold-increase values from 0.5 to 2-fold that of WT. All strains grew like WT on rich
medium except for fhl1, which had a 2.5-fold higher doubling time.

About 2/3 of the new mutants with abnormal capsules also showed defects in at least one
other virulence-related trait (Fig. 3.3.C, left). Several showed defects in all traits measured,
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including usv101, a novel virulence regulator (Fig. 3.2). We also identified three novel factors,
Hap2, Bik1, and Mlr1, that are not involved in regulating capsule, but do yield isolated melanin
defects (Fig. 3.3.C, right); Mlr1 further has no S. cerevisiae ortholog. Notably, all four TF
mutants with reduced capsule shedding that we tested in mice had an infectivity defect. This
suggests that capsule shedding is critical for infectivity, regardless of whether surface capsule is
reduced or enlarged.

Figure 3.3.C. Aberrant phenotypes of new mutants (left) and of all the mutants in Fig. 2 (right). Melanin was scored
for 37 °C phenotype.

3.5.2 PhenoProphet accurately predicts which TFs will have altered capsule
thickness
A remarkably large fraction of the TFs identified by PhenoProphet were involved in
capsule regulation (Appendix Table 1). We compared this result to our previous strategy of using
the correlation of gene expression with capsule thicknesses to predict TF capsule involvement,
using our previously published correlation scores (Haynes et al. 2011). Of the 17 TFs we
selected for deletion by the correlation method, 8 had altered capsule thickness (47%); of the 10
we selected by PhenoProphet, 8 had aberrant or hypervariable capsule thickness (80%). To
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further compare capsule-size correlation and PhenoProphet to each other and to other methods of
phenotype prediction, we applied each method to a set of TFs for which the capsule phenotype of
the corresponding deletion was known. These genes had primarily been deleted because they
were suspected to have a role in capsule regulation (Appendix Table 2.B). To simulate
prospective phenotype prediction, we used leave-one-out cross validation, in which each mutant
phenotype is predicted without using any data derived from that mutant. As a simple, baseline
prediction method, we considered the hypothesis that TF genes that display significant
expression changes upon capsule induction are more likely to be required for normal capsule
induction than those that do not. The data did not support this hypothesis (Fig. 3.4.A, green).
Next, we considered the possibility that genes whose expression is significantly correlated with
capsule thickness would be more likely to encode TFs regulating capsule than genes whose
expression is not correlated with capsule thickness. The data did not support this hypothesis,
either (Fig. 3.4.A, red).

Figure 3.4.A. Comparison of methods for predicting capsule involved regulators. Four expression-based methods (xaxis) were used to predict whether cryptococcal regulators are involved with capsule formation (mutants show
abnormal capsule; dark bars) or not (light bars). The set of genes in each category was then assessed for the fraction
that actually does influence capsule (y-axis).
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We next tried a phenotype prediction method called Phenologs, which is based on the
observation that genes sharing a phenotype in one organism often share phenotypes in another
organism, even when the phenotypes themselves appear to be unrelated (McGary et al. 2010).
However, TFs with positive Phenolog scores were not significantly enriched for those that affect
capsule thickness (Fig. 3.4.A, blue; Fisher’s exact p=0.43), nor were the Phenolog scores of TFs
that do affect capsule thickness greater, on average, than those of TFs that do not (Fig. 3.4.B,
blue; Mann-Whitney U test p=0.33). Thus, Phenolog scores do not have discriminative value in
this application. In contrast to all of these methods, TFs with positive PhenoProphet scores were
significantly enriched for those that affect capsule thickness (Fig. 3.4.A, orange; Fisher’s exact p
< 0.03). Furthermore, the mean of PhenoProphet scores for TFs that affect capsule thickness was
significantly greater than the mean score for TFs that do not affect capsule thickness (Fig. 3.4.B,
orange; Mann-Whitney U test p < 0.02).

Figure 3.4.B. Comparison of scores assigned by methods for predicting capsule involved regulators. Mean and SEM
of Phenolog and PhenoProphet scores for genes which are capsule involved (dark bars) or not (light bars).

The predictive power of PhenoProphet relative to the other methods is confirmed by
receiver operating characteristic analyses (Fig. 3.4.C).
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Figure 3.4.C. Receiver operating characteristic analysis comparing the indicated methods for phenotype prediction
to random expectation (dotted line).

Next, we investigated the effect of the number of expression-profiled TF deletion strains
on the accuracy of PhenoProphet. The results showed that the predictive accuracy of
PhenoProphet exceeded chance (and the accuracy of Phenologs) even when the number of
profiled TF-deletion strains given to NetProphet was reduced to 25% of the total (11 TFs
deleted; Fig. 3.5.A). Providing profiles of more TF-deletion strains increased accuracy,
confirming that PhenoProphet depends on the NetProphet network for its accuracy. In
applications where no TF network is available and the number of TF-deletion strains that can be
profiled is less than 10 another method (such as Phenolog analysis) may be most useful. We also
investigated the effect of the number of known capsule-involved genes, with results similar to
those described above for deletion-strain profiles (Fig. 3.5.B.)
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Figure 3.5.A-B. Examination of PhenoProphet accuracy in varying conditions. Panel A, effect of number of
regulator-deletion expression profiles given to NetProphet on the accuracy of PhenoProphet. Panel B, effect of the
number of known phenotype-linked genes on PhenoProphet accuracy.

3.5.3 NetProphet predicts functional, direct binding of TFs to their targets
We previously validated NetProphet in S. cerevisiae using data from ChIP-chip and
protein-binding microarrays (Haynes et al. 2013). To validate NetProphet in C. neoformans, we
focused on Gat201, the only cryptococcal TF for which ChIP data was available (Chun et al.
2011); Nrg1, a well studied capsule regulator (Cramer et al. 2006); and Usv101, a capsule
regulator described here for the first time. We epitope-tagged the last two and carried out ChIPseq. We then tested the NetProphet-predicted targets of Usv101, Gat201, and Nrg1 for
significant overlap with their ChIP-positive targets. NetProphet assigns a confidence score to
each potential target of a TF, so we tested top-scoring target groups of various sizes, from 40 to
200. For all three TFs, the 40 most confident NetProphet predictions were highly enriched for
ChIP-positive targets, as compared to the number that would be expected if 40 genes were
chosen at random (Fig. 3.6.A-C).
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Figure 3.6.A-C. ChIP enrichment of NetProphet predicted targets. Colored bars, cumulative fold-enrichment of the
top NetProphet-predicted targets of each TF for ChIP-positive targets, relative to the fraction of ChIP-positive
targets among all genes; square symbols, significance of the enrichment (pval). The horizontal axis indicates the
number of top-ranked NetProphet-predicted targets considered.

To further test our predictions, we compared models of TF binding specificity inferred
from the NetProphet-predicted targets to specificity models derived from ChIP (Fig. 3.6.D-F, top
two logos). For both Usv101 and Gat201, the Cryptococcus motifs derived from NetProphet
predictions and from ChIP data were highly similar, whereas for Nrg1 there were significant
differences between the two. For comparison, we extracted a motif for the closest homolog of
each TF in S. cerevisiae from the ScerTF database (Spivak and Stormo 2012) (Fig. 3.6.D-F,
bottom logo). The motif of C. neoformans Usv101 (confirmed independently by NetProphet and
ChIP) has diverged substantially from the motif of S. cerevisiae Usv1 on one side. No motif is
available for Gat2, the ortholog of Gat201, but the motif of Ecm23, the next best homolog,
shows the expected GATA family resemblance. The motif for S. cerevisiae Nrg1 supports the
ChIP-derived Cryptococcus motif over the NetProphet-derived motif; this is likely because the
NetProphet-predicted Nrg1 targets include some indirect targets regulated by TFs downstream of
Nrg1.
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Figure 3.6.D-F. Comparison of derived binding motifs. For the indicated TFs, C. neoformans binding motifs derived
from the promoters of NetProphet-predicted targets (top) or from the regions around ChIP-seq peaks (middle) are
compared to S. cerevisiae binding motifs (bottom).

We then attempted to infer binding specificity models (PWMs) for all other Cryptococcus
TFs from their NetProphet-predicted target sets (Elemento and Tavazoie 2005). We tested these
PWMs for significant conservation in the genome of a related species (JEC21, serotype D). We
also tested each TF to determine whether there was a highly homologous TF in S. cerevisiae with
highly similar binding specificity, as in Figure 3.6.D, E. In total, 18 PWMs showed both types of
conservation and were therefore deemed reliable models (Fig. 2.6). Previously, binding
specificity was known for only 2 TFs in Cryptococcus (Chun et al. 2011; O'Meara et al. 2014),
both of which strongly support our independently derived PWMs.

3.5.4 ChIP-experiments validate NetProphet predictions
We combined NetProphet and ChIP results from Usv101, Gat201, and Nrg1 to produce a
high-confidence core for our model of the network regulating virulence in C. neoformans (Fig.
3.6.G). This reveals a highly interconnected subnetwork in which Usv101 represses GAT201,
consistent with their opposite capsule phenotypes (large vs. small). Usv101 also represses several
sugar transporters while activating HXT1, a hexose transporter that has a hypercapsular
phenotype (Chikamori and Fukushima 2005). Usv101 represses, and Gat201 activates, BLP1,
which is involved in a capsule-independent anti-phagocytic mechanism (Chun et al. 2011). The
opposing effects of Usv101 and Gat201 on BLP1, which promotes fungal survival during
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infection, are consistent with their generally opposing roles in regulating virulence and their
opposite capsule phenotypes. Usv101 represses BLP1 both directly and via its repression of
GAT201, forming a coherent feed-forward loop.

Figure 3.6.G. Network diagram showing the three validated TFs with targets supported by both NetProphet and
ChIP analysis that are relevant to cryptococcal virulence. Round nodes, TFs; square nodes, target genes or gene
ontology biological process terms for which the targets of the indicated TF are enriched. Blue nodes, mutants are
hypocapsular; yellow nodes, mutants are hypercapsular; gray nodes, mutants are defective in capsule-independent
phagocytosis. Edges with arrowheads indicate activation while those with T-heads indicate repression. ChIP
evidence suggests that Usv101 binds to its own promoter but expression evidence cannot determine whether this
binding results in activation, repression, or no effect.

Our data support a previous report (Chun et al. 2011) that Gat201 activates ECM2201,
encoding a TF, and we report for the first time that the ecm2201 mutant is hypocapsular (Fig.
3.2). Gat201 has the same effect on capsule size as Nrg1 and works with Nrg1 to stimulate
expression of GAT204, which encodes a second TF involved in the capsule-independent antiphagocytic mechanism (Chun et al. 2011). Both Gat201 and Nrg1 repress some genes involved
in cell wall synthesis but Nrg1 also activates other genes involved in cell wall synthesis,
suggesting that cell wall may be reconfigured during capsule induction. Nrg1, which is activated
by cAMP signaling in Cryptococcus (Cramer et al. 2006), also activates PDE2, encoding a
phosphodiesterase that reduces cAMP levels (Zaman et al. 2008), thus adding a slow,
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transcriptionally-mediated negative feedback loop in cAMP signaling to the fast, posttranslational negative feedback loops that have been reported (Hicks et al. 2005; Kronstad et al.
2011).
Nrg1 further activates UGD1, MAN1, and UXS1, which encode glycoactive proteins (Fig.
3.6.G), as well as CLC-A and CPL1, which encode proteins involved in maintaining ion balance
(Zhu and Williamson 2003 and our unpublished data). Deletion of any of these five genes results
in a hypocapsular phenotype. Thus the hypocapsular phenotype of the nrg1 mutant may be
caused by its failure to activate expression of these five genes. Broadly speaking, the TFs in Fig.
3.6.G have the same phenotypes as the targets they activate. Furthermore, TFs whose absence
affects capsule thickness in opposite directions (Usv101 vs. Gat201 and Nrg1) regulate their
common targets in opposite directions, whereas TFs whose absence affects capsule in the same
direction (Gat201 and Nrg1) also regulate their common targets in the same direction.

3.5.5 NetProphet illuminates transcriptional dynamics
To gain insight into the transcriptional dynamics of cryptococcal capsule induction, we
performed RNA-seq on WT cells immediately before transfer from rich media into capsuleinducing conditions and at 1.5, 3, 8, and 24 h after transfer. Considering all genes across the time
course (Fig. 3.7.A), one pattern that emerged was repression of genes involved in ribosome
biogenesis, tRNA synthesis and processing, amino acid biosynthesis, and protein transport, along
with induction of genes involved in specific amino acid degradation and protein degradation; this
is consistent with the cells accommodating to scarcer nutrients and slower growth. Expression of
some nuclear genes encoding cytochrome-C oxidase (COX) components declined while
expression of mitochondrial genes encoding COX components increased. Expression of all 13
mitochondrial genes increased significantly (mean fold-change 57, median 20).
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Figure 3.7.A. heat map of genome-wide expression profiling; blue, low expression; yellow, high expression.
Examples of functional annotations of genes in each cluster are indicated.

To map the transcriptional dynamics onto our network, we divided TFs whose deletions
alter capsule thickness into four groups based on their temporal expression patterns (Fig. 3.7.B,
circles). The most “upstream” acting TFs in the network form a group with slightly increased
expression at 90 minutes followed by sharply decreased expression over the next 24 hours (Fig.
3.7.B, Regulator Group 1). This group includes activators of ribosome biogenesis genes and
repressors of mitochondrially-encoded respiration genes. It also contains repressors of a cluster
of capsule-involved genes whose expression increases steadily through capsule induction (Fig.
3.7.B, Box A). This target group includes genes encoding proteins involved in nucleotide sugar
synthesis and transport, polysaccharide synthesis, and maintenance of inorganic ion and osmotic
balances. Group 1 includes activators of a set of capsule-involved genes that decreases steadily
after the first few hours of capsule induction (Fig. 3.7.B, Box B). These declining genes include
four that encode proteins that promote cAMP/PKA signaling, reinforcing the transcriptionally
mediated negative feedback on cAMP/PKA signaling noted above.
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Figure 3.7.B. Regulatory relations among groups of capsule-involved genes clustered by temporal expression
pattern. Circles, groups of regulators clustered by their temporal expression patterns (insets); text denotes
representative functions of their activated (green) or repressed (red) targets. Boxes, capsule-involved target genes
clustered by their temporal expression patterns (insets); text provides examples of target gene functions. Green
arrows, activation of designated targets; red T-heads, repression of designated targets. Regulator Group 1 is Clr1,
Hap5, Nrg1, Pkr1, and Ssn801; Regulator Group 2 is Cac1, Cep3, Cir1, Clr2, Fap1, Fhl1, Fkh2, Gat1, Mcm1,
Pdr802, Sp1, Swi6, and Usv101; Regulator Group 3 is Clr6, Hog1, Mbs1, Ste12alpha, and Tup1; Regulator Group 4
is Ada2, Clr3, Clr4, Clr5, Ecm2201, Fkh101, Gat201, Hap3, and Rim101. NSS, nucleotide sugar synthesis; NST,
nucleotide sugar transport; ROS, reactive oxygen species.

Group 2 is the opposite sign partner of Group 1 and cooperates with it in nearly every
way: Its expression pattern is opposite that of Group 1 and it regulates mitochondrially-encoded
respiration genes as well as each cluster of capsule-involved non-TFs in the opposite way from
Group 1. Since Group 2 is repressed by Group 1 the indirect effects of Group 1 via Group 2 are
consistent with the direct effects of Group 1.
As with Group 2, the expression of regulators in Group 3 decreases from time 0 to 90
min, then reverses course and increases from 90 min to 24 hr. The difference is that Group 2
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regulators rapidly recover to well beyond their initial levels, whereas Group 3 regulators never
recover their initial levels. This difference may result from the tendency of Group 2 regulators to
activate each other, forming positive feedback loops. Group 3 regulators activate genes involved
in the response to reactive oxygen species (ROS) while repressing certain carbohydrate and
amino acid transporters. Group 3 regulates a set of capsule-involved genes that has an “L”
shaped expression pattern (Fig. 3.7.B, Box C) and includes genes involved in amino acid
biosynthesis and other growth- related processes.
Group 4 regulators are regulated by all of the other groups but they do not regulate other
groups, putting them at the bottom of the hierarchy. Their expression increases steadily through
induction and they include activators of genes involved in metal ion transport and synthesis of
chitin, a component of cell wall.
Taken together, these analyses show a hierarchy of TFs (circles), with those expressed in
an “inverted check-mark” (Group 1) at the top, those that first decrease and then increase in the
middle, and those that increase steadily at the bottom. Capsule-involved, non-TF genes (boxes)
are expressed in temporal patterns that are generally consistent with those of their regulators –
the same pattern for activators and the opposite for repressors. These observations suggest that
the temporal patterns of downstream genes can in many cases be explained by the patterns of
their regulators shown in Figure 3.7.B. For example, Group 1 and Group 2 regulators that are
connected by an edge in the underlying network show an average temporal correlation of -0.84.
For Group 1 and Group 3, the average correlation is -0.16 and for Group 2 and Group 4 it is
+0.60.
The fact that we do not see any delay between the changes in upstream regulators and
those in downstream targets is consistent with the expectation that the translation of TF-encoding
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mRNAs and the initial response by target genes should occur on a faster time scale (< 0.5 hr)
than the interval between samples in our time course (1.5-16.0 hr).
The hierarchical relationships among these four regulator groups were confirmed by
comparing the number of factors regulating each regulator to the number of its targets (Fig.
3.7.C). This analysis shows that the regulators in Group 1 have more targets than regulators,
those in Groups 2 and 3 have about the same number of targets and regulators, and those in
Group 4 have more targets than regulators.

Figure 3.7.C. Normalized hierarchy heights (NHH) of regulators in Groups 1-4 of Fig. 3.7.B. NHH is the number of
outgoing edges minus the number of incoming edges divided by outgoing plus incoming.

3.5.6 Network analysis reveals mechanisms of capsule biosynthesis regulation
While little is known about the glycosyltransferase reactions that generate capsule
polysaccharides, the upstream pathways that form precursors for this process are well defined.
Nucleotide sugar donors of mannose, galactose, glucuronic acid, and xylose are synthesized in
the cytosol and transported into the Golgi for use in capsule synthesis (Fig. 3.8.A). We analyzed
our network to gain insight into the regulation of these key metabolic processes. PSA101 is the
most heavily regulated of the genes we analyzed, suggesting that it is a key point at which
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transcriptional regulation affects biosynthesis. Of the two genes encoding GDP-mannose
transporters, GMT1, which has a much greater effect on capsule size (Wang et al. 2014), is
regulated by the major capsule regulators Cir1 (Jung et al. 2006), Rim101 (O'Meara et al. 2014),
and Ada2 (Haynes et al. 2011). GMT2, whose deletion shows a phenotype only when GMT1 is
also inactivated (Wang et al. 2014), is repressed by Usv101 and activated by Rds2, a TF without
a significant capsule thickness phenotype. The degree of regulation by capsule- involved TFs
thus highlights the transporter that is more heavily involved in capsule synthesis.

Figure 3.8.A. Regulation of upstream capsule biosynthetic pathways. Network-derived regulatory relationships
between TFs and the pathways that make and localize sugar donors for capsule synthesis, considering the top 10,000
NetProphet edges. Large labeled arrows, synthetic steps; ovals, TFs; cylinders, nucleotide sugar transporters in the
Golgi membrane. Shapes are labeled with the corresponding gene name and filled blue if the mutants are
hypocapsular, yellow if the mutants are hypercapsular, and white if the gene has not been deleted (PMM1) or the
mutants have normal capsule thickness (all others). Arrowheads indicate activation and T-heads repression; edge
colors reflect the phenotype of the regulator. ASG1+2 represents 3 genes which are normocapsular when deleted:
ASG1, CCD6, and MAL13; HAP3,5 represents HAP3 and HAP5, both hypocapsular when deleted. Man, mannose;
Xyl, xylose; GlcA, glucuronic acid; Glc, glucose; Man1, phosphomannose isomerase; Pmm1,
phosphomannomutase; Psa1, GDP-mannose pyrophosphorylase; Uxs1, UDP- Xyl synthase (Bar-Peled et al. 2001);
Ugd1, UDP-Glc dehydrogenase (Bar-Peled et al. 2004; Moyrand and Janbon 2004); and Uge1, UDP-Glc epimerase.
Gmt1 and Gmt2 are GDP-Man transporters (Cottrell et al. 2007; Wang et al. 2014) and Ugt1 is a UDP-Gal
transporter (Moyrand et al. 2007); transporters for the other precursors have not been identified.

The TFs that regulate the largest number of genes involved in upstream capsule
biosynthetic processes are Nrg1, whose mutant is severely hypocapsular, closely followed by
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Usv101, whose hypercapsular deletion phenotype is reported here for the first time, Cir1,
Rim101 and Ada2. Regulation of capsule biosynthetic enzymes and transporters is sufficient to
explain the phenotypes of mutants lacking Cir1, Nrg1, Usv1, and Ada2: Usv101 (hypercapsular)
primarily represses these pathways while the others (hypocapsular) primarily activate them. The
hypocapsular phenotype of rim101 is less well explained, as Rim101 appears to repress UXS1
and GMT1 while activating PMM1 and PSA1. Likewise, the phenotypes of mbs1 and fkh2 are not
explained by the relationships we have identified, suggesting that some of their other targets may
have as-yet-unknown roles in capsule synthesis.
The TFs that regulate the metabolic pathways shown in Fig. 3.8.A also regulate one
another in what is largely a feed-forward hierarchy (Fig. 3.8.B). Cir1, Nrg1, and Usv101 sit at
the top of the hierarchy, each regulating multiple other TFs. The other regulator at the top of the
pathway is Ccd3, which interestingly does not have a capsule size phenotype despite activating
four TFs with hypocapsular phenotypes. Clr2, Mbs1, Fkh2, Hap5, and Bik1 form an intermediate
layer, and Hap3, Rds2, Rim101, and Ada2 appear at the bottom of the cascade because they
regulate enzymes and transporters directly but do not regulate other TFs in this context. Of the 7
TFs that regulate only one or two biosynthetic genes in Fig. 3.8.A and do not regulate other TFs
in Fig. 3.8.B, only 1 is required for normal capsule thickness. In contrast, all 5 of the TFs that
regulate 3 or more genes in Fig. 3.8.A are required.
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Figure 3.8.B. Network-derived regulatory relationships between the TFs shown in Figure 3.8.A, using the same
colors and symbols except that TFs are circles. For clarity, only the top 10,000 NetProphet edges were used.

3.6 Discussion
NetProphet and PhenoProphet enable individual labs lacking the resources of a genome
center to systematically and efficiently study the transcriptional regulation of a specific
physiological process. Currently, the TFs that regulate a process of interest are typically
discovered by large-scale mutant screens and TF-target relations are mapped in big-science
projects that do not focus on TFs with specific biological functions (Harbison et al. 2004; Hu et
al. 2007; Kemmeren et al. 2014). Our approach brings TF discovery and mapping together
through focused, iterative network construction and analysis. We demonstrated this approach by
mapping the network that regulates the major virulence factor of Cryptococcus neoformans, a
deadly human pathogen. Key to the success of this effort was PhenoProphet’s accuracy in
identifying TFs that are required for normal capsule growth. This enrichment for TFs involved in
capsule regulation enabled us to perform quantitative capsule-size assays that are more sensitive,
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but also more labor-intensive, than those used in traditional screens. Our approach enables TF
networks to be mapped using only gene perturbation and expression profiling, both of which are
straightforward in most experimental systems. Indeed, the number of TF-perturbation expression
profiles for mammalian systems is growing rapidly, facilitating the application of our approach
to mammals. No single approach has perfect sensitivity and specificity, so large-scale mutant
screens and ChIP-seq remain important complementary methods. Nonetheless, we have filled a
significant methodological gap between single-gene approaches and undirected genomic
approaches.
Using the NetProphet-PhenoProphet approach, we produced a comprehensive map of the
TF network that regulates cryptococcal capsule size, increased the number of TFs known to
regulate capsule from 11 to 27, and increased the number of C. neoformans TFs with known
sequence specificity from 2 to 18. In the course of this work, we generated a rich resource for
systems biology of fungal virulence. We increased the number of publically available RNA-seq
profiles from C. neoformans TF-deletion studies 20-fold, more than doubled the total number of
Cryptococcus expression profiles (including microarrays), presented the first time course of
expression during capsule induction, and generated virulence-related phenotypes for 41 regulator
deletion mutants under identical conditions, including all known TF mutants that affect capsule
size. Taken together, our data sets form the most comprehensive resource for regulatory systems
biology available for any fungal pathogen. We expect that this data set, like large-scale data sets
for S. cerevisiae (Harbison et al. 2004; Hu et al. 2007), will catalyze the development of
powerful new network analysis and phenotype prediction algorithms.
Our kinetic evaluation of gene expression during capsule induction allowed us to cluster
major regulators based on their temporal expression patterns. We found that the TFs comprising
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Group 1 decrease in expression during capsule induction, releasing repression of Group 2 TFs,
which correspondingly increase in expression. Groups 1 and 2 have strikingly similar net effects
through opposite expression patterns and opposite effects on target expression, forming coherent
feed forward loops. Our dynamic analysis also revealed how regulators interact to influence
general cellular processes as well as capsule synthetic pathways. For example, the Group 1 and 2
regulators cooperate to induce mitochondrially-encoded respiration genes, resulting in massive
upregulation of these genes (mean, 57 fold; median, 20 fold). This is interesting because host
conditions are hypoxic (Erecinska and Silver 2001) and the virulence of Cryptococcus gattii,
which can cause fatal infections in immunocompetent individuals, is closely associated with
upregulation of mitochondrial gene expression (Ma et al. 2009). We also integrated our broad
analysis of transcriptional dynamics with our focused analysis of nucleotide sugar regulation.
Both analyses highlight hierarchies of transcription factors that are largely consistent with one
another. They agree that Nrg1 is at the top, regulating many capsule-involved TFs but not itself
transcriptionally regulated. They further agree that Hap3, Rim101, and Ada2 are at the bottom,
regulated by many TFs and regulating relatively few, and that Usv101, Mbs1, and Fkh2 play
both roles, integrating signals from master regulators and distributing them to lower level
regulators.
Much of the downstream machinery required for capsule polysaccharide synthesis has
not yet been identified. We expect that the NetProphet network, in addition to efficiently
identifying novel capsule regulators, will address this gap. For example, we noticed that
CNAG_03320 (the more diverged of two cryptococcal homologs of the S. cerevisiae GDPmannose pyrophosphorylase Psa1) was regulated by large numbers of capsule-involved TFs,
suggesting that it might have a role in synthesizing capsule precursors. When we tested this idea
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by deleting the gene, now named PSA101, the mutants were indeed severely hypocapsular.
Another way in which the network can highlight relevant biosynthetic machinery is illustrated by
Ecm2201, a TF that is required for normal capsule growth but does not regulate any other genes
known to be required for normal capsule. We anticipate that the targets of Ecm2201 and other
TFs with unexplained phenotypes include missing elements of capsule biosynthetic pathways.
Filling in these gaps in knowledge about synthesis of a major virulence factor that has no parallel
in human cells may help identify targets for future antifungal therapy.
In addition to capsule size, we assayed our matched set of mutants for other virulencerelated phenotypes, including capsule shedding, melanization, and infectivity in a short-term
mouse model. This revealed some surprising relationships among phenotypes. Many of our novel
TF mutants that affected capsule thickness also affected infectivity, with both hypercapsular and
hypocapsular mutants showing reduced infectivity. Hypercapsular mutants were particularly
impaired in this regard. This is consistent with a recent report that virulence in C. neoformans is
positively correlated with rate of uptake by macrophages, which is negatively correlated with
capsule size (Sabiiti et al. 2014). Reduced capsule shedding was a strong and significant
predictor of reduced infectivity (p. < 0.03). Thickness and shedding were not clearly related,
suggesting that these processes are independently regulated and that enlarged capsules might
result from increased production in some cases and reduced shedding in others. We also
observed that deletion of TFs frequently increases capsule size variability, showing that
variability is controlled by TFs, probably through negative feedback loops.
In this work, we report a significant advance in the efficiency with which TFs that
regulate a specific biological process can be identified and their regulatory networks mapped.
We further used that technical advance to gain major insights into fungal virulence regulation. In
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the process we produced a valuable resource for regulatory systems biology of fungal pathogens,
comprising high quality gene expression and phenotype data produced by a single laboratory
using a consistent strain background. We expect that our methodological advances will have a
broad impact in systems biology and that our discoveries and data resources will transform our
understanding of fungal virulence.

3.7 Methods
3.7.1 Materials, strains, and cell growth
Cell culture media (i.e. Dulbecco’s Modified Eagle’s Medium, D6429), chemicals (i.e. LDOPA for melanization, D9628), and PCR primers were from Sigma- Aldrich, PCR purification
(28106) and gel extraction (28706) kits from Qiagen, and reagents used for RNA-seq, such as the
SuperScript III Kit (18080) and the mRNA Catcher Plus Kit (K1570), from Life Technologies.
Strains were made in C. neoformans KN99α (Nielsen et al. 2005) with standard growth at 30 °C
in yeast peptone dextrose (YPD) medium. For capsule induction, an overnight culture in YPD
was washed, resuspended in DMEM, and grown at 37°C in 5% CO2.

3.7.2 Gene manipulation and naming
A split-marker strategy (Fu et al. 2006) was used to replace specific genomic targets with
drug resistance cassettes as in (Haynes et al. 2011) and to incorporate HA tags; New gene names
were CLR, capsule-linked regulator; MLR, melanin- linked regulator; and CCD, capsulecorrelated DNA-binding protein.

3.7.3 Phenotyping
Growth in vitro was assessed by cell counts, melanization by colony color on L- DOPA
agar, and shed capsule polysaccharide by the Cryptococcal Antigen Latex Agglutination System
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(CALAS®, Meridian Bioscience, Cincinnati, Ohio). To assess capsule thickness, duplicate
cultures of cells grown for 24 h in inducing conditions were washed and mixed 3:1 (v/v) with
India ink for imaging. The cell wall and capsule edge of each cell were manually annotated (≥10
images per culture) using custom software, and the capsule thickness (outer capsule edge
diameter minus cell wall diameter) of mutants relative to WT cells grown in parallel was
calculated. Only significant differences (p<10-7) of more than 2.5 pixels were reported as altered
capsule thickness.

3.7.4 RNA Isolation, RNA-seq, and ChIP-seq
RNA was isolated by standard methods from ≥3 biological replicates for each strain
grown for 90 min in capsule-inducing conditions. Libraries for RNA-seq were prepared as in
(Haynes et al. 2011), barcoded, and pooled in equimolar ratios for multiplex sequencing. ChIP
studies were performed as in (Haynes et al. 2011), using WT and HA-tagged strains and
comparing samples subjected to immunoprecipitation (IP) to input material and mock
precipitated samples.

3.7.5 Animal Studies
All animal studies were reviewed and approved by the Animal Studies Committee of
Washington University School of Medicine and conducted according to NIH guidelines. Groups
of six 6 week-old female C57Bl/6 mice were inoculated intranasally with 1.25 × 104 cryptococci,
and lung CFU were determined at 2 h and 7 d post-infection.

3.7.6 Comparison of phenotype prediction methods
The accuracy of each method was assessed by comparing its predictions to the
phenotypes of 50 single-regulator deletion strains that have been analyzed for capsule thickness
either by us or in published works (Appendix Table 2.B). Most of these genes were deleted
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because they were thought likely to have capsule phenotypes – they are not a random sample of
all cryptococcal TFs and 32 of them had altered capsule thickness. Differential expression was
assessed using standard methods. Capsule size correlation was assessed as in (Haynes et al.
2011). Phenologs were assessed as in (McGary et al. 2010). The PhenoProphet score of a TF for
capsule thickness is –log p-value from the hypergeometric test for enrichment of its NetProphetpredicted targets for genes that are known to have capsule thickness phenotypes. Specifically, the
PhenoProphet score is the maximum –log p-value over all networks consisting of the top n
NetProphet predictions, with n ranging from 500 to 40,000 in increments of 500. To compute the
NetProphet and PhenoProphet scores of a TF we did not use any information about the
phenotype or expression profile of the corresponding deletion mutant.

3.7.7 Network validation
For Gat201 (CNAG_01551), we used published ChIP data (Chun, Brown, & Madhani,
2011). For Nrg1 (CNAG_05222) and Usv101 (CNAG_05420) we carried out ChIP-seq as above.
For each TF, a ChIP-based sequence-specific binding motif was inferred using BioProspector
(Liu et al. 2001). Promoter regions were defined as the 1,000 bp upstream of the start codon. A
NetProphet- based binding motif was also inferred by inputting NetProphet’s target confidence
scores for each TF to FIRE (Elemento, Slonim, & Tavazoie, 2007). The motifs of orthologous
TFs from S. cerevisiae were obtained from ScerTF (Spivak and Stormo 2012). If the motif for
the best S. cerevisiae match was unknown the next best match was used. A network of
interactions that were supported by both ChIP and NetProphet was constructed using the top
10,000 NetProphet predictions.
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3.7.8 Transcriptional dynamics of capsule induction
Triplicate cultures of WT cells were sampled for RNA-seq at 0, 1.5, 3, 8, and 24 h after a
shift to capsule-inducing conditions. For each gene, a temporal expression signature was
constructed from its median expression level at each time point. For each pair of genes the
correlation between their temporal signatures was converted to a dissimilarity. Gene clusters
were formed by applying hierarchical agglomerative clustering and cutting the resulting
dendrogram at the 10-branch level. For each cluster, GO and KEGG functional enrichment
analysis were performed, over-represented terms were examined in detail, and relevant terms
were selected. The heatmap was created by scaling the expression of each gene to span the range
from 0 to 1.
Temporal expression signatures for capsule-involved regulators and capsule-involved
non-regulators were clustered separately into four groups each (Fig. 3.7.B, circles and boxes,
respectively). One of the groups of non-regulators is not shown, as we had no comment on it. A
combined signature was generated for each cluster by taking the median expression level of all
genes in the cluster at each time point. If the number of NetProphet-predicted activating
(repressing) edges from one regulator group to another was enriched 1.5-fold relative to an even
distribution of the activating (repressing) edges among regulator groups then the corresponding
activating (repressing) edge was shown in Figure 3.7.B. The analogous calculations were made
for edges from regulator groups to non- regulator groups.

3.7.9 Data access
All generated RNA-seq and ChIP-seq data have been submitted to the NCBI Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE60398. A
software package that implements PhenoProphet is available at http://mblab.wustl.edu/.
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Chapter 4:
Transcriptome Engineering Promotes a
Fermentative Transcriptional State
4.1 Abstract
The rational manipulation of transcriptomes offers the possibility to engineer the cell as a
collective unit toward specified goals, revolutionizing medicine and bioengineering. Progress in
transcriptome engineering has primarily consisted of experimental approaches that are iterative,
slow, and expensive. We have developed a novel algorithm, NetSurgeon, which utilizes genomewide gene regulatory networks to identify interventions that will force a cell toward a desired
expression state. Following extensive in silico validation, we applied NetSurgeon to S. cerevisiae
biofuel production, generating interventions designed to promote a fermentative state during
xylose catabolism. Our selected interventions successfully promoted a fermentative
transcriptional state in the absence of glucose and generated strains with 120% higher xylose
import rates, improved xylose integration into central carbon metabolism by 303%, and
increased ethanol production rates by 31%. We conclude by presenting an integrated model of
transcriptional regulation and metabolic flux that will enable metabolic engineering efforts to
prioritize functional regulators of central carbon metabolism.
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4.2 Background
The central promise of regulatory systems biology is that a map of the cell’s global
connectivity will enable us to understand, predict, and rationally manipulate cellular behavior.
The manipulation of cellular state has many promising applications, including stem cell biology
and regenerative medicine, biofuel production, and gene therapy. Fundamental progress toward
the goal of cellular state control has been advanced via systems biology - the study of cellular
behavior as a complete unit, and synthetic biology - a rapidly advancing discipline which aims to
design regulatory and effector molecules with defined behaviors. In systems biology, immense
resources have been invested in genome sequencing, systematic deletion collections, and
massively parallelized data acquisition, leading to network maps and improved understanding of
the cell as a complete system (Gerstein, et al., 2012). However, relatively little research has
focused on using these network models for the prediction and manipulation of cellular behavior
(Chuang, Hofree, & Ideker, 2010). Synthetic biology has focused on creating molecular
components that can be placed into a system to modify the transcriptional state of a small
number of genes. However, genome-scale regulatory engineering is still rare, with most systems
restricted to a small number of regulators and a limited set of controlled targets (Cameron,
Bashor, & Collins, 2014). Bridging the gap between these two disciplines, we demonstrate that
the integration of functional transcriptional network mapping, gene expression profiling, and
computational modeling can be used to rationally engineer cellular state.

4.3 Related Work
Transcriptome engineering focuses on the manipulation of extant cellular networks and
regulatory systems to enforce a state associated with a desired cellular phenotype. The use of
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native cellular regulatory mechanisms and network models enables the investigator to access
evolutionarily optimized states and avoid the extensive iteration often associated with the
integration of a synthetic regulatory circuit into a host system (Cardinale & Arkin, 2012)
(Litcofsky, Afeyan, Krom, Khalil, & Collins, 2012). The majority of transcriptome engineering
thus far has taken place within the context of developmental stem cell engineering, with the
generation of induced pluripotency being the best example (Takahashi & Yamanaka, 2006).
Since the development of induced pluripotent stem cells, many transcriptional interventions have
been identified that move cells at various developmental stages along a specified lineage (Morris
& Daley, 2013). However, current strategies for direct lineage conversion are often unable to
fully convert cells to the state of the goal cell fate (Feng et al. 2008; Marro et al. 2011; Morris et
al. 2014).
The CellNet algorithm was developed in response to current deficiencies in cellular
engineering. CellNet is a network-guided algorithm for determining how completely an
engineered cell recapitulates a target cell state and identifying transcriptional interventions to
guide further engineering (Cahan et al. 2014). CellNet identifies sub-networks within mouse and
human cell-type-specific regulatory networks whose expression state is predictive of the cell
type. These predictive sub-networks are used as features for classifying novel gene expression
profiles according to the cell type they most resemble. In addition, CellNet selects TF
interventions for transcriptome engineering by computing a Network Influence Score for each
TF which is the sum of two components: the dysregulation of the regulator weighted by its
expression level and the dysregulation of its targets weighted by their expression levels. This
approach for target selection intervention was used to guide B cell to macrophage conversion by
knocking down B cell regulators (Morris et al. 2014). The generalizability of this method
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remains unclear due to the limited number of interventions and evaluations performed. These are
exciting demonstrations of the power of transcriptome engineering, but studies in these complex
developmental systems are limited by incomplete transcriptional network maps, complex cell
culture requirements, and a lack of quantitative phenotypes directly linked to molecular effectors.
These issues have thus far prevented a quantitative assessment of transcriptome engineering
efforts.

4.4 Approach
In order to quantitatively assess the current state of transcriptome engineering and
establish benchmarks, we utilized S. cerevisiae as a model system. 196 of the 209 transcription
factors (TF) with an annotated DNA-binding domain in the S. cerevisiae genome possess a
known DNA binding specificity (Spivak & Stormo, 2012) (Weirauch, et al., 2014) and the
genome-wide effect of TF removal on expression has been quantitated through microarray
profiling (Hu, Killion, & Iyer, 2007) (Kemmeren, et al., 2014). These data provide us with the
ability to generate an accurate network model and to validate our algorithmic approaches. The
simplicity of S. cerevisiae culture enables quantitative modeling and assessment, with the
input/output metabolic function measurable by HPLC and the transcriptional state of the cell
quantitated by RNA sequencing.
We identified the industrially relevant fermentation of the pentose carbohydrate xylose as
a prototype application that met all our criteria for the quantitative assessment of transcriptome
engineering. Xylose is a component of hemicellulose, a polymer that represents approximately
23% of lignocellulosic biomass and is not efficiently fermented by S. cerevisiae into ethanol
(Chandel & Singh, 2011). Biochemical research has identified all enzymes required for the
integration of xylose into the cell’s central carbon metabolism. However, recombinant yeast
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strains expressing these enzymes, and grown in mixed glucose/xylose cultures, rapidly ferment
all available glucose and then undergo a diauxic shift into a respiratory metabolic state.
Salusjarvi et al demonstrated through transcriptional and proteomic analysis that cells grown on
xylose exist in a hybrid fermentative/respiratory state (Salusjärvi, et al., 2008). The abundance of
systems-level data, known metabolic pathways, clear regulatory constraint and quantitative
phenotypes enabled us to utilize the transcriptome engineering of xylose metabolism to evaluate
the current state of transcriptome engineering.
In this work we present a novel algorithm, NetSurgeon, designed to enable transcriptome
engineering. We ran this algorithm over genome-wide gene regulatory networks (GRN)
generated using NetProphet (Haynes et al., 2013), and assessed its performance at selecting TFs
whose deletion or overexpression will move the transcriptional state of the cell toward a desired
goal. Following algorithmic validation, we applied the algorithm to engineer a fermentative
xylose transcriptional state and assessed global cellular response to our transcriptional
interventions by using analytical chemistry. Our results demonstrate that transcriptome
engineering can be efficiently guided using network models and reveal the degree of
transcriptional control over a quantitative multi-factorial phenotype.
Our transcriptome engineering method, NetSurgeon, simulates interventions on a
transcriptional network model to prioritize those that are likely to move the transcriptional state
towards a goal state. Our transcriptome engineering efforts consisted of three steps. First, a map
of the network of direct, functional regulation is built (Fig. 4.1.A). Second, starting and goal
transcriptional states are defined and our algorithm for prioritizing TF interventions, NetSurgeon,
searches through the all possible interventions (deletion or overexpression) to identify
interventions that are likely to move the transcriptional state towards the goal state (Fig. 4.1.B).
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Finally, strains containing the predicted best interventions are created and RNA-seq and HPLC
are used to quantitatively assay their transcriptional and metabolic state (Fig. 4.1.C).

Figure 4.1. Overview of the computational and experimental approaches for rational control of transcriptional state.
Panel A: Approach for generation of a gene regulatory network model from DNA binding specificity information
and gene expression profiling. Panel B: Approach for target selection through intervention simulation and regulator
prioritization. Panel C: Approach for quantitative assessment of intervention effect via RNA sequencing and HPLC
metabolite profiling and modeling.

We built an integrated gene regulatory network map by building and combining separate
functional and physical maps. The functional map was itself constructed by combining maps
inferred by NetProphet from three large expression datasets (Chua, et al., 2006) (Gasch, et al.,
2000) (Hu, Killion, & Iyer, 2007). NetProphet is a state-of-the-art GRN mapping algorithm that
combines a differential expression (DE) analysis and a co-expression analysis. The physical map
was built using a combination of TF binding information from both chromatin
immunoprecipitation (ChIP) implicated TF target interactions (Abdulrehman, et al., 2010)
(Balaji, Babu, Iyer, Luscombe, & Aravind, 2006) (Harbison, et al., 2004) (Lee, et al., 2002) and
TF binding potential estimated by scanning a collection of position weight matrix (PWM)
models over all yeast promoters (Spivak & Stormo, 2012). An integrated functional and physical
GRN map was built by assigning a score to each TF-target gene pair that was equal to the
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geometric mean of the scores assigned to it in the functional and physical networks. The
geometric mean ensures that high scoring interactions are supported by both binding and
expression evidence.
To select interventions that will shift transcriptional state toward the goal state, we
applied NetSurgeon. This algorithm assigns a score to each possible intervention representing its
confidence that the intervention will yield a shift toward the goal state. The score assigned to
each intervention is based on the number of targets of the regulator that are predicted to move
toward the goal state and degree to which the initial and goal states differ for the regulator and
targets. Deletion of a TF is predicted to increase expression targets it represses and decrease
expression of targets it activates. Conversely, overexpression of a TF is predicted to decrease
expression targets that the TF represses it and increase expression targets it activates. Highscoring interventions are those that are predicted to change many genes in the right direction,
with greater weight given to targets that are the most significantly differentially expressed genes
between the initial state and goal state.

4.5 Results
4.5.1 Network models can efficiently guide transcriptome engineering efforts
To assess the ability of NetSurgeon to select interventions that will move the initial
transcriptional state toward the goal state, we used NetSurgeon to select regulator interventions
for single regulator intervention goal states from publically available gene expression datasets.
We choose to use independent single regulator intervention expression profiles for validation
goal states, rather than randomly generated expression states, because randomly generated
expression states may not be biologically achievable. We constructed the GRN used for
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validation in a similar fashion as previously described, except the functional network was
inferred from only one of the three gene expression datasets previously used, the dataset
consisting of 269 regulator deletions strains grown in YPD (Hu, Killion, & Iyer, 2007).
We initially examined NetSurgeon’s performance on goal states that we knew could be
achieved by a single TF deletion mutant growing in synthetic complete medium (SC). This
medium was different from the rich medium (YPD) in which the expression profiles used to
build the network were obtained, but the two media featured the same sugar: 2% glucose. The
goal states were an independent set of expression profiles from regulator deletion mutants
(Kemmeren, et al., 2014). For each of the 245 goal states, NetSurgeon used the
NetProphet+PWM network to assign scores to all 320 possible regulator deletions. We plotted
the number of goal states for which NetSurgeon ranked the best intervention (the one that
actually produced the goal state profile) at or above each rank (Fig 4.2.A, green). We compared
this to a random assignment of rankings for each of the deletion goal states, by running
NetSurgeon on 100 random networks of the same topology (Fig. 4.2.A, gray). We found that
NetSurgeon is able to assign higher scores to the correct interventions compared with ranks
assigned by running NetSurgeon over randomly generated networks (Mann-Whitney U test P <
10-46). Further, we observed that NetSurgeon performed at random chance levels using the
permuted networks, indicating network structural accuracy is critical for NetSurgeon
performance. We also assessed the ability of NetSurgeon to identify the best intervention within
the top 5 scoring interventions, a reasonable number of interventions to test experimentally.
NetSurgeon ranks the best intervention in the top 5 for 91 goal states, which is 29-times better
than random networks scores (P<10-165).
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Figure 4.2.A. In silico assessment of NetSurgeon using 245 deletion mutant expression profiles grown in synthetic
complete medium. Plotted curves show the number of goal states for which NetSurgeon ranked the best intervention
at or above each rank (green), compared with random ranks (gray).

We also evaluated the ability of NetSurgeon to indentify interventions in cells cultured in
conditions even further from those used to construct the GRN. The goal states consisted of 63
expression profiles obtained from regulator overexpression strains grown in selective synthetic
medium supplemented with 2% galactose (Chua, et al., 2006). We assessed the scores assigned
to the best regulator for each overexpression goal state and compared the outcome to scores
generated using random networks (Fig. 4.2.B). We found that NetSurgeon is able to assign
higher scores to the correct interventions compared with random network generated scores
(Mann-Whitney U test P < 10-6). NetSurgeon is also able to assign the best intervention a top 5
rank for 8 of the 63 goal states (13%), a 10 fold improvement over the mean of the random
network
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Figure 4.2.B. In silico assessment of NetSurgeon using 63 overexpression strains grown in grown in selective
synthetic medium supplemented with 2% galactose. Plotted curves show the number of goal states for which
NetSurgeon ranked the best intervention at or above each rank (green), compared with random ranks (gray).

In order to evaluate the effect of network accuracy on NetSurgeon performance, we
applied NetSurgeon to GRNs inferred from the same expression data sets by CLR (Faith, et al.,
2007), regression (Bonneau, et al., 2006), NetProphet (Haynes, et al., 2013), and NetProphet
integrated with PWM scores. We first evaluated the structural accuracy of the five GRNs by
determining the level of ChIP support for high confidence interactions in each GRN. We then
evaluated the performance of NetSurgeon when using each of these five GRNs on our two test
data sets: the TF-deletion in SC glucose and TF-overexpression in SC galactose. We plotted the
structural accuracy of each of the five GRNs against the NetSurgeon’s accuracy when using that
GRN (Fig. 4.2.C). We observed a clear pattern of improved NetSurgeon performance with more
structurally accurate GRNs. A level-log regression model was fit to test this observation
(Multiple R2 = 0.853, P=0.00014) and forecasted a maximum NetSurgeon intervention recovery
of 0.85 AUC with a perfect network model, which is a 33% improvement over current
NetSurgeon performance.
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Figure 4.2.C. In silico assessment of the effect of network structural accuracy on NetSurgeon target intervention
selection accuracy. Network structural accuracy of five GRNs, summarized by area under the precision recall curve
at 5% ChIP recovery (x-axis), is compared with NetSurgeon intervention target selection accuracy, summarized by
area under the curve of the number of goal states for which NetSurgeon ranked the best intervention at or above
each rank (y-axis). Gray dotted lines indicate chance 5% ChIP recovery AUC and cell state selection AUC.

To assess the practicality of NetSurgeon-guided engineering, we ran NetSurgeon on the
NetProphet+PWM network and computed the median number of interventions needed to identify
the first, the best, and all deletion genotypes that reduce the distance between the wild-type cells
and the goal by at least 10% (Fig. 4.2.D). A median of 12, 22 and 51 mutant strains were
required to recover the first, the best, and all interventions (10-, 7-, and 4-fold better than
random, respectively).
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Figure 4.2.D. In silico assessment of the median number of NetSurgeon interventions required to generate any
strain, the best strain, or all strains, that will converge expression state at least 10% towards the goal state (green),
compared with random ranking (gray).

4.5.2 Application of transcriptome engineering to biofuel production
Following the successful in silico validation of our approach for transcriptome
engineering, we applied the algorithm to the industrially relevant problem of ethanol production
in a mixed glucose-xylose co-culture. Principle components analysis of RNA-seq data from S.
cerevisiae cells grown with xylose as the sole carbon source indicated that the system was in a
hybrid transcriptional state with some characteristics of cells grown in 2% glucose, a
fermentative state, and some characteristics of cells grown in 1.3% ethanol, a respiratory state
(Fig. 4.3.A). As S. cerevisiae cells do not natively consume xylose, we hypothesized that the
system was unable to recognize the pentose carbohydrate as a fermentable carbon source and
therefore entered into a transcriptional state that was non-optimal for fermentative metabolism.
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Figure 4.3.A. Principal component analysis of RNA expression profiles reveals a state transition between cells
grown on 5% glucose (green), 5% xylose (blue), and 1.3% ethanol (red).

We therefore sought to identify interventions that would shift the system from the xyloseonly transcriptional state (origin state) to the high-glucose state (goal state). In order to apply
NetSurgeon to this problem, we generated the integrative, genome-wide network map described
above. Using this map, NetSurgeon produced a rank-ordered list of regulators whose deletion
was predicted to force the system toward the 2% glucose transcriptional state. From this rank
ordered list, we selected the top eight predicted interventions for biological validation via PCRmediated genetic deletion of the selected regulators in the H2217-7 yeast strain (Table 4.1). In
order to assess the combinatoric effect of the predicted deletions, we generated an additional
three strains carrying deletions in two of the NetSurgeon-selected regulators (cat8/hap4,
cat8/adr1, cat8/aft2). For a limited comparison of our algorithmically selected deletions with
expert intuition, we deleted the master regulator SNF1, the yeast ortholog of AMP kinase and a
critical regulator responsible for glucose repression and other features of fermentative
metabolism.
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WILD-TYPE

SINGLE KO

DOUBLE KO

H2217-7

snf1

cat8/adr1

adr1

cat8/hap4

cat8

cat8/aft2

usv1
gis1
msn2
hap4
msn4
aft2
Table 4.1. Wild-type and deletion mutant strains profiled

We found that the NetSurgeon-selected targets were supported by existing literature. Cat8
and Hap4 are respiratory factors active in the general cellular response to xylose and deletion of
HAP4 was recently shown to improve cellobiose consumption rates (Salusjärvi, et al., 2008)
(Lin, et al., 2014). MSN2 and MSN4, encoding stress associated factors, were observed to be
highly upregulated in xylose and their transcriptional targets misregulated (Matsushika,
Goshima, Hoshino, & others, 2014). Usv1, Gis1 and Aft2 were all found to have clear roles in
the yeast transcriptional response to non-fermentable carbon sources and general stress response
(Hlynialuk, Schierholtz, Vernooy, & der, 2008) (Pedruzzi, Bürckert, Egger, & Virgilio, 2000)
(Blaiseau, Lesuisse, & Camadro, 2001).
Aerobic batch fermentations were used to assess the outcome of our transcriptome
interventions at the transcriptional and metabolic levels. Cells were inoculated into synthetic
complete medium supplemented with 2% glucose and 5% xylose at an OD600 of 1.0+/- 0.2 and
grown for 48 hours. Samples were taken for RNA-sequencing at 4 hours and 24 hours,
representative of the glucose-xylose and xylose-only metabolic states. Aliquots were acquired for
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HPLC metabolite analysis across the 48 hour fermentation (Fig. 4.3.B). Using this data, we
examined the NetSurgeon’s ability to control transcriptional state and quantitatively assessed the
effect of transcriptome transcriptional state change on a complex phenotype.

Figure 4.3.B. Top: Glucose (light blue), xylose (dark blue), and ethanol (red) metabolite concentration profiles from
the fermentation of the wild-type H2217-7. Bottom: Overview of RNA-seq (magenta) and HPLC (turquoise)
sampling strategy for aerobic batch fermentations used in this study.

4.5.3 Transcriptome engineering successfully promotes a fermentative state:
Differential expression analysis revealed that 2,887 genes are differentially expressed by
at least two fold in wild-type cells as a result of glucose depletion (42% of all genes. Fig. 4.4.A).
Six of the eight NetSurgeon-selected interventions lowered the number of differentially
expressed genes. The cat8 mutant was the best, preventing the change in expression of 1,182 of
2,887 DE genes while creating only 526 new DE genes, for a net reduction of 656 DE genes.
Notably, the deletion of CAT8 reduced differential expression better than the deletion of SNF1, a
master regulator of the S. cerevisiae glucose repression system.
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Figure 4.4.A. Number of 2-fold or greater differentially expressed genes between the wild-type strain in the
fermentative state and each strain in the respiratory state. Green and red bars indicate strains with less and more
differentially expressed genes than wild-type respectively.

Next, we calculated the Euclidean distance between the wild-type expression state in the
glucose-xylose phase and the deletion strain’s expression state in the xylose-only phase (Fig.
4.4.B). Six of the eight NetSurgeon interventions lowered the Euclidean distance between the
two phases. The single deletion mutant cat8 reduced the genome-wide expression distance
between the glucose-xylose phase and the xylose-only phase by 28.4%. The mean reduction in
Euclidean distance of the six successful NetSurgeon selected interventions was 20.8%. As in the
DE analysis, the deletion of HAP4 and ADR1 increased the total distance between the two state
vectors.
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Figure 4.4.B. Euclidean distance between the full expression profile of wild-type strain in the fermentative state, and
the full expression profiles of all strains in the respiratory state. Green and red indicate reduced and increased
Euclidean distance compared with wild-type respectively.

The NetSurgeon-selected interventions were specifically targeted at optimizing the
expression state of 445 genes involved in carbon metabolism. Among these 445 genes, the cat8
deletion mutant reduced the Euclidean distance by 36% (Fig. 4C). On average, the six successful
NetSurgeon-selected interventions reduced the Euclidean distance between the two state vectors
by 24%.
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Figure 4.4.C. Euclidean distance between the expression 445 metabolically active computationally optimized genes
in the fermentative state of the wild-type strain, and the matching optimized gene expression profiles of all strains in
the respiratory state. Green and red indicate reduced and increased Euclidean distance compared with wild-type
respectively.

Each of the eight NetSurgeon selected transcription factors had known roles in the
regulation of the cellular stress response or respiratory processes. We evaluated the ability of
each transcription factor to promote a fermentative state across specific metabolic pathways (Fig
4.4.D). With the exception of adr1, each deletion mutant affected the expression of genes across
many of the metabolic pathways in central carbon metabolism. Seven of the eight NetSurgeonselected interventions lowered the Euclidean distance in at least one of the central carbon
metabolism pathways evaluated. All six of the interventions that reduced differential expression
and global Euclidean distance moved the expression of glycolytic genes toward a fermentative
state.
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Figure 4.4.D. Euclidean distance between the expression profiles of central carbon metabolic pathways in the
fermentative state of the wild-type strain, and the matching central carbon metabolic pathway expression profiles of
all strains in the respiratory state. Green and red indicate reduced and increased Euclidean distance compared with
wild-type respectively.

Three of these interventions shifted the expression of TCA cycle genes toward a
fermentative state. Deletion of CAT8 promoted a fermentative state in many metabolic pathways
essential for xylose fermentation, including genes involved in glucose utilization, the pentose
phosphate pathway, glycolysis, the TCA cycle, and acetate/glycerol production. All of the TCA
cycle genes were moved toward the expression level associated with fermentative metabolism
(Fig 4.4.E). Deletion of CAT8 also reduced the Euclidean distance of all TCA genes from the
fermentative state by 60%. These observations highlight the power of transcriptome level
interventions to modulate the expression of many more genes than is feasible by traditional, onegene-at-a-time genetic engineering.
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Figure 4.4.E. Comparison of the expression TCA cycle genes between the fermentative state of the wild-type strain
(red), the respiratory state of the wild-type strain (green), and the respiratory state of the cat8 deletion mutant strain
(blue).

4.5.4 Identification of transcriptional states associated with improved
fermentation
In order to assess the change in cellular metabolic behavior following our transcriptional
interventions, we profiled metabolic intake and output via HPLC. HPLC analysis identified three
metabolic states associated with high glucose, low glucose, and respiratory metabolic phases. We
focused our downstream analyses on the high glucose and respiratory phases of the fermentation
during which we had carried out RNA-seq.
To examine the ability of the selected transcriptional interventions to control the
metabolic state of the cell, we calculated the percentage of input carbon that end up in each of
the major carbon fates in each phase (Fig 4.5.A, 4.5.B). Carbon import rates significantly
declined in the absence of high glucose, with a mean reduction of import across all assayed
genotypes by 86%. In addition to changes in import rate, the cells significantly upregulated their
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commitment of carbon to respiratory processes in the xylose-only phase. Carbon commitment to
respiration changed from a mean of 24% in the glucose-xylose phase to 89% in the xylose-only
phase. This indicated that the metabolism of all strains had shifted into a respiratory mode during
the xylose-only phase (Fig. 4.5.B).

Figure 4.5.A-B. Transcriptome interventions alter carbon intake rates, but do not prevent a transition to a respiratory
metabolism. Panel A: Cellular metabolic input and output across profiled genotypes during the glucose-xylose phase
of aerobic fermentation. Panel B: Cellular metabolic input and output within the xylose phase.

Although the tested interventions did not prevent the transition to a respiratory metabolic
state, they did affect the cell’s commitment of carbon to output metabolites significantly. We
observed 41 statistically significant changes in carbon commitment across the 13 profiled
genotypes (p<0.05, t-test, Benjamini-Hochberg corrected). 28 of these changes were within the
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glucose-xylose phase. Carbon commitment to all of the profiled metabolites and phenotypes was
altered in at least one of our transcriptional interventions, indicating that changes in
transcriptional state have the power to impact all dimensions of cellular metabolism. Carbon
commitment to xylitol was significantly increased in transcriptional interventions associated with
respiratory processes, a potential side effect of the respiratory factors modulating the ratio of the
Xyl1, Xyl2, and Xks1 enzymes required for xylose integration into central carbon metabolism.
Interestingly, all significant changes in carbon commitment to ethanol and biomass were
reductions. The deletion of SNF1, HAP4, USV1, GIS1, MSN4 and AFT1 significantly reduced
carbon commitment to ethanol, with a mean reduction in carbon flux by 26%. Deletions
involving CAT8 or HAP4 significantly reduced carbon commitment to biomass by 33% and
38%, respectively, in the glucose-xylose phase of the fermentation.
We also observed 57 statistically significant changes in the specific rates of metabolite
production or consumption across the glucose-xylose and xylose-only phases of the fermentation
(p < 0.05, t-test, Benjamini-Hochberg corrected). Within the glucose-xylose phase, we identified
industrially relevant changes in glucose and xylose consumption rates, acetic acid output and
ethanol production. All of the profiled interventions on respiratory regulators (cat8, hap4, adr1)
improved the specific rate of glucose consumption between 11% and 40% (Fig. 4.5.C). We
found that hap4 and msn4 mutants improved the specific rate of xylose consumption by 170%
and 120% respectively (Fig. 4.5.D). Acetic acid, a fermentation byproduct demonstrated to
inhibit glycolysis, was also produced at 53%-83% lower specific rates in the hap4 and cat8
mutants (Fig. 4.5.E) (Pampulha & Loureiro-Dias, 1990). Importantly, the specific rate of ethanol
production was significantly increased by 22% and 31% in the cat8 and hap4 mutants (Fig
4.5.F). Within the set of stress associated factors, we found that the deletion of USV1, MSN2,
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MSN4 and AFT2 significantly reduced the specific rate of ethanol production, with a mean rate
reduction of 22% (Fig 4.5.F). Taken together, these data demonstrate the ability of transcriptome
engineering to generate significant changes in cellular behavior, even in the absence of complete
phenotypic conversion.

Figure 4.5.C-F. Transcriptome interventions alter specific rates of metabolite production or consumption in the
glucose-xylose phase. Panel C: Specific rate of glucose consumption. Panel D: Specific rate of xylose consumption.
Panel E: Specific rate of acetic acid production. Panel F: Specific rate of ethanol production.

4.5.5 An integrated model of transcriptional regulation and metabolic flux
The lack of data linking transcriptional state with metabolic phenotypes has prevented the
use of transcriptional interventions for effective engineering of metabolism. In order to address
this issue, we utilized our dataset to construct an integrated model of S. cerevisiae central carbon
metabolic flux and expression. We identified regulators linked to flux by correlating their
expression with pathway carbon flux. From this set of regulator-flux correlations, we identified
regulators putatively controlling metabolic flux outcomes via network-predicted direct regulatory
relationships (Fig. 4.6).
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Figure 4.6. An integrated map relating transcription factors to central carbon metabolism flux. Blue rounded
rectangles: pathways in central carbon metabolism. Green ovals: transcription factors. Links between transcription
factors and pathways denotes transcription factor expression correlation with increased (black arrow headed link) or
decreased (red circle headed link) flux through the pathway. Solid link lines: transcription factor directly regulates
the expression of genes in the pathway.

This analysis revealed that three transcriptional regulators were deeply interconnected
with biochemical pathways important for xylose metabolism and fermentation. CAT8 expression
was correlated with genes associated with xylose utilization, the pentose phosphate pathway,
acetate production and the TCA cycle. Msn4 was predicted to directly regulate genes involved in
xylose utilization, the pentose phosphate pathway, and the TCA cycle, and flux through these
pathways was anti-correlated with MSN4 expression. Pdr3 was revealed to be a regulator of
glycolytic genes, and flux through these pathways was positively correlated with PDR3
expression. This integrated model of transcriptional regulation and metabolic flux is an important
step toward the rational engineering of S. cerevisiae metabolism.
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4.6 Discussion
We have demonstrated that transcriptional network maps can be used to rationally
manipulate cellular state by identifying the crucial regulators mediating a state transition and
prioritizing them for genetic intervention. The formalization of this process of rational state
manipulation is expected to enable future developments in personalized medicine, improve
approaches to stem cell engineering, and reduce the costs associated with these efforts. Our work
establishes quantitative benchmarks in this new field, enabling the rapid progress generally
associated with clear benchmarks (Stolovitzky, Monroe, & Califano, 2007).
The availability of deletion and overexpression collections in S. cerevisiae has enabled us
to assess the state of the art in network-guided transcriptome engineering. We found that
NetSurgeon can identify the best intervention within a median of 22 guesses, a 7-fold
improvement over random guessing. We observed that network amps built from data on one
environmental condition can be successfully used to predict interventions in different conditions.
This is important for applications that deviate from standard environmental conditions. Finally,
we have demonstrated the utility of TF-network maps enriched with direct regulatory
relationships; maps generated by NetProphet together with PWM models led to selections that
were substantially better than those made by using maps expression correlation or CLR.
We applied NetSurgeon to optimizing yeast for ethanol production from glucose-xylose
co-culture. NetSurgeon selected critical regulators highlighted in the literature and six of the
eight promoted a fermentative transcriptional state. Although the single deletions were
insufficient to entirely prevent a state transition involving 43% of the yeast genome, it succeeded
in significantly changing the rate and ratio of cellular carbon commitment. We found that
regulators associated with respiratory processes had significant metabolic effects in the
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fermentative phase of the culture. We also found that deletion of transcription factors controlling
stress response lowers the rate of production and the total ethanol yield. In addition, our dataset
of 8,055 metabolic measurements with 73 matched RNA sequencing profiles across 14
genotypes will enable future engineering efforts to identify and rationally manipulate the critical
regulators of metabolic flux in order to maximize biofuel production.
One of the advantages of transcriptome engineering is the possibility of accessing
evolutionarily optimized states associated with specific phenotypes. The expression levels of
genes within linear metabolic pathways such as glycolysis and the TCA cycle are highly
regulated in order to maintain a correct ratio of enzyme products necessary for avoiding
intermediate metabolite accumulation and allosteric inhibition of upstream processes. The
engineering of optimal expression levels across entire pathways is a challenging problem that is
often addressed through iterative selection strategies (Wang, et al., 2009). We observed that
manipulation of regulator expression levels is a promising strategy to access pre-defined
expression states across entire pathways. The effect of CAT8 deletion on TCA gene expression is
one example of an interventions reconfiguring the expression of an entire pathway toward a
fermentative state. The TCA cycle within S. cerevisiae consists of twenty-six genes, making
optimization of this pathway’s expression level a difficult task through one-gene-at-a-time
engineering. Cat8 was predicted by NetProphet to regulate four genes within the TCA cycle and
the glyoxylate pathway, and removal of this factor was predicted to move the TCA cycle toward
a fermentative expression configuration. We found that CAT8 deletion moved all twenty-six
genes of the TCA cycle toward a fermentative state, providing evidence that naturally evolved
transcriptional states can be leveraged for transcriptome engineering.
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Our analysis of the double deletion strains highlighted the complexity of epistatic effects
within gene regulatory networks. Although the generation of strains with multiple regulatory
perturbations offers the possibility of large scale reconfiguration of cellular state, we observed
that the three double deletion strains failed to reduce differential expression and Euclidean
distance as much as their component single deletions. This non-additivity between genotypes
indicates that a more sophisticated approach to modeling the effect of multiple regulator
perturbations will be required to expand target selection approaches multiple perturbations.

4.7 Methods
4.7.1 Network guided target selection
To rank possible regulator interventions for convergence towards a goal expression state,
NetSurgeon uses a GRN to simulate interventions for all regulators, and for each simulated
regulator intervention a score is assigned representing the confidence that the regulator
intervention will converge the expression state towards the goal state. The score for a simulated
regulator intervention is based on the enrichment of the regulator’s simulated intervention effects
to fix the total dysregulation of all genes between the initial and goal expression states, where the
total dysregulation of all genes is quantified by the sum of the negative log pvals of significance
of differential expression. Specifically the NetSurgeon network intervention score for a regulator
is:
NetSurgeon network intervention score (Ri) = max( -log10 ( hypergeometric distribution(Xij *
for network cutoff j = 500, …, 40,000

(W/D), W, U-W, (Xij+Yij) * (W/D) + Cij - Zij)))

where U is the total number of genes in the network, W is the number of dysregulated genes, D
is total amount of dysregulation, Xij is the total amount of dysregulation that the intervention of
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regulator Ri will remove when considering only the top j interactions in the network, Yij is the
total amount of dysregulation that the intervention of regulator Ri will make worse when
considering only the top j interactions in the network, Cij is the total number of genes regulated
by regulator Ri when considering only the top j interactions in the network, and Zij is the total
number of dysregulated genes regulated by regulator Ri when considering only the top j
interactions in the network.

4.7.2 Strain engineering
The xylose metabolizing strain VTT-C-99318 (CEN.PK2-1D ura3::XYL1 XYL2
his3::XKS1 kanMX) was acquired from Salusjarvi et al. and used as the base strain for all
experiments in this study (Salusjärvi, et al., 2008). The At5g17010 xylose transporter from A.
thaliana was transformed into the VTT-C-99318 strain and maintained through the use of
dropout media (Hector, Qureshi, Hughes, & Cotta, 2008). The genetic deletion of algorithmically
selected transcription factors was accomplished through PCR amplification and targeting of drug
cassettes to the selected ORF via the addition of 45 base pairs of homologous sequence to the
5’/3’ amplifying oligos (Baudin, Ozier-Kalogeropoulos, Denouel, Lacroute, & Cullin, 1993).
Prior to use in experimentation, all strains were freshly plated onto selectable media from frozen
stocks.

4.7.3 S. cerevisiae fermentations
All S. cerevisiae strains were grown aerobically in 60 mL of synthetic complete at 30℃
in 250 mL baffled erlenmeyer culture flask shaken at 225 RPM. Cultures for identification of
differential expression associated with carbon sources were grown in triplicate in either 50 g/L
glucose, 50 g/L xylose or 1.3 g/L ethanol for 8 hours prior to collection of biomass for RNA
sequencing. Culture of cells for evaluation of the impact of transcriptional interventions were
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performed in triplicate and initiated by inoculating 1.0+/- 0.2 OD600 units of biomass into 60
mL of synthetic complete media supplemented with 20 g/L glucose and 50 g/L xylose. Samples
taken for RNA-seq analysis were aliquoted from the primary culture, spun down at 3000xg and
frozen in liquid nitrogen prior to downstream analysis. The supernatant of samples for HPLC
was collected by centrifugation of culture samples at 12,000xg for 3 minutes prior to snap
freezing for storage in a dry ice/ethanol bath. All samples were stored at -80℃. At least two
independent experiments of three biological replicates was performed for each genotype
evaluated by HPLC. Cellular density was quantitated through analysis of culture turbidity at 600
nm.

4.7.4 Metabolite analysis
The concentration of input and output cellular metabolites was analyzed using HPLC.
Supernatant solutions were stored at -80℃ and filtered through the use of 0.22 um syringe prior
to HPLC analysis. Metabolites were eluted from an Aminex HPX-87H column maintained at
65℃ and peaks detected by refractive index. Identified peaks were quantified through integration
and interpolated against serial dilutions of standards for glucose, xylose, xylitol, glycerol, acetic
acid and ethanol. Analysis of HPLC data was performed on a per biological replicate basis, with
metabolic input/output relationships quantified across each fermentation and pooled into a single
distribution based on genotype. Turbidity measurements were converted into units of g/biomass
based on the turbidity to biomass conversion factor published (Hector, Qureshi, Hughes, &
Cotta, 2008). Calculations of analyte rate and specific rate of change were performed across
steady states identified in the ethanol dimension. In order to evaluate internal carbon flux, a
system of linear equations was developed to describe central carbon metabolism in S. cerevisiae.

88

The system of equations was fit to experimentally measured parameters of carbon import and
export for each genotype across the glucose/xylose and xylose-only phases of each fermentation.

4.7.5 RNA sequencing and analysis
Total mRNA was isolated using the yeast RiboPure kit (Life Technologies, Carlsbad
CA). Libraries for RNA-Seq were prepared as in (Haynes, et al., 2011). Briefly, poly(A) RNA
was selected from the total RNA isolated as above using the mRNA Catcher Plus Kit (Life
Technologies) with an epMotion 5075 automated pipettor (Eppendorf). The poly(A) RNA was
subsequently sheared by incubating in TURBO DNA-free buffer at 75°C for 10 minutes and
purified with the QIAquick PCR Purification Kit (Qiagen). First strand cDNA synthesis was
performed using random hexameric primers and SuperScript III Reverse Transcriptase, followed
by treatment with E. coli DNA ligase, DNA polymerase I, and RNase H for second-strand
synthesis, all using standard methods. The cDNA libraries were end-repaired with a Quick
Blunting kit and A-tailed using Klenow exo- with dATP (New England Biolabs). Illumina
adapters were ligated to the cDNA and fragments ranging from 150-250 bp in size were selected
using gel electrophoresis. The libraries were enriched and indexed in a 10-cycle PCR using
Phusion Hot Start II High-Fidelity DNA (Fermentas), purified, and pooled in equimolar ratios
for multiplex sequencing on an Illumina HiSeq 2500.

4.7.6 RNA/metabolic data integration and analysis
We utilized two different complementary methods for integrating RNA expression
profiles and metabolic data in order to gain a better understanding of the molecular mechanisms
controlling metabolic phenotypes. First, we used the limma software package (Ritchie, et al.,
2015) to identify differentially expressed genes within the fermentative and respiratory states
between the wild-type strain and each deletion strain. We then used this differential expression
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analysis to putatively link genes mechanistically to metabolic analyte outcomes by identifying
differentially expressed genes in metabolic pathways linked to each metabolic analyte.
In addition to differential expression analysis, we also identified genes linked to
metabolic outcomes by identifying genes whose expression significantly correlates with carbon
flux. For each gene and each metabolic pathway we computed the Pearson correlation coefficient
between the gene’s expression profile, and the computed carbon flux through the pathway. We
then generated a null distribution of correlation coefficients between gene expression and
pathway flux by randomly generating 10,000 expression vectors by sampling per condition from
the expression of all genes within the condition with replacement. These null distributions of
expression correlation with pathway flux were then used to assign false discovery rate corrected
p-values to the significance of each gene’s expression correlation with flux measurements of a
metabolic pathway.
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Chapter 5:
Discussion
5.1 Conclusion
The central promise of Systems Biology is that a map of the cell’s global connectivity will
lead to the ability to understand, predict and manipulate cellular behavior in a rational fashion.
With the advent of high throughput experimental approaches to assay gene expression state, and
subsequent computational methods to infer gene regulatory network structure over the past 15
yeas, our ability to measure and model cellular decision making has improved greatly. However,
to truly reach the goal of rational engineering of cellular state, transcriptional network models
must have the capacity to predict expression and physiological phenotype state in novel
conditions. This dissertation examined and applied strategies to utilize the predictive power of
gene network models to guide experimental and engineering efforts.
In chapter 2 we identified the need for improved causative regulatory network models, and
then integrated expression based functional interaction evidence and TF binding based physical
interaction evidence, in order to utilize the full predictive power of gene network models. These
causative network models are vital to understanding the information flow through the network,
which allows for expression prediction and cellular engineering. In response, we developed a
method to enrich the most confident edges of an inferred network model with edges that are
supported by functional and physical evidence. This method combines the strengths of multiple
approaches to network building by iterating between expression based network building, and de
novo inference of TF binding specificity using the network interactions and protein homology.
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We applied this approach to infer the Saccharomyces cerevisiae and Cryptococcus neoformans
regulatory networks and TF binding motifs and, in Cryptococcus neoformans, we were able to
identify 18 TF binding motifs, of which 15 are novel.
In Chapter 3, we inferred a model of the regulatory network in Cryptococcus neoformans
controlling the fungal pathogen’s capsule and we utilized this network to generate physiological
phenotype predictions which guided further experimentation. The integrated analysis pipeline
presented in this chapter demonstrates the power of regulatory networks to predict phenotypes
and guide experimental efforts; this approach allowed us to identify 16 novel regulators
controlling the capsule, which is a substantial improvement from the 11 previously known
regulators. Also, we used the final network model to gain a better understanding of cryptococcal
capsule biology through analysis of regulation of the enzymes and transporters responsible for
biosynthesis of capsule sugars and modeling the dynamics of capsule induction.
In Chapter 4, we investigated the power of causative regulatory networks to guide a real
cellular engineering application. To facilitate engineering efforts we presented a novel algorithm,
NetSurgeon, which scores simulated overexpression and deletion interventions based on the
confidence that each intervention will move the expression state towards a desired goal state. We
validated our algorithm through extensive in silico testing using existing large publically
available expression profiling datasets of deletion and overexpression regulator interventions in
S. cerevisiae. Then, we applied our NetSurgeon method to engineer S. cerevisiae strains with
improved biofuel production. NetSurgeon selected 8 TF deletion strains predicted to promote a
fermentative transcriptional state, normally occurring in a glucose-rich medium, in an
environment containing only the alternative carbon source xylose. We found that 6 of the 8 TF
deletion strains successfully moved the transcriptional state of xylose-consuming cells toward a
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fermentative state. In addition, we observed improved industrially relevant metabolic phenotypes
in several of our intervention strains including 120% higher xylose import rates and 31%
increased ethanol production rates. Finally, we generated a map linking transcriptional control to
metabolic flux through the central carbon metabolic pathway and highlighted several regulators
critical for future metabolic engineering efforts.
Taken together, these chapters represent the first thorough examination, systematic
application, and quantitative evaluation of the utilization of network models for predicting
unobserved expression and phenotype state and guiding biological research. In this work we
advance the network biology field by utilizing the predictive power of networks, rather than
focusing on network structural accuracy. We believe that in the future quantitative novel
genotype expression prediction will become viable with improvements in the accuracy and
perturbation simulation of direct and functional regulatory models. In addition, we believe that
many more datasets will assay cellular state in multiple dimensions and phenotypes, allowing for
more complete cellular modeling and engineering. We are on the cusp of fulfilling the promise of
Systems Biology to allow for prediction and manipulation of cellular behavior.

5.2 Future Directions
Chapter 2 presents a method to improve causative network model inference and de novo
inference of TF binding specificity models by integrating the two tasks. Although this approach
was successfully demonstrated, there are several limitations that could be improved with
additional research effort. Currently, a relatively simple method for calculating the binding
potential score is scanning a PWM over a promoter sequence and adding the significant hits.
However, adopting a more biologically motivated strategy would allow for the computed binding
potential to better reflect the observed binding in ChIP experiments. DNA sequence conservation
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is a strong predictor of TF binding sites that could be included in the binding potential scoring by
up-weighting significant PWM hits that occur in conserved regions of DNA (Stormo 2013). In
addition, experimentally validated binding of TFs has been observed to cluster around
transcription start sites. Therefore, a weighting based on the distance of the PWM hit from the
transcription start site could also improve the binding potential scoring scheme (Ouyang et al.
2009).
Besides strengthening the scoring scheme used to construct the physical network model,
future work will likely improve on the methods used to combine the functional and physical
transcriptional network models. In Chapter 2, the score assigned to each interaction in the
combined model is the geometric mean of the interaction scores in the expression based
functional model and binding based physical model. Unlike arithmetic mean, the geometric mean
function requires interactions to be support by both binding and expression evidence in order to
be high scoring. However, the geometric mean function does not allow for the consideration of
interactions between the functional and physical evidence, which could boost the confidence in
the existence of an interaction. If for example, we observe an enrichment of physical binding
support for interactions in which a TF is predicted to activate its targets, then we may infer that
the TF is an activator, and boost the score of activating interactions. Unfortunately, due to the
lack of trustworthy labeled data, it is difficult to synthesize functional and physical regulatory
models into a single causative model by applying supervised machine learning methods. There is
a rich literature of unsupervised and semi-supervised methods that should be investigated, such
as rank aggregation and co-training. In addition to generating better functional and physical
combined models, improving and standardizing methods to integrate a variety of interaction
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evidence into a single network model will become more important as more types of interaction
features, like chromatin marks, become widely available.
In Chapter 3, we integrated the often separated processes of computational modeling and
experimentation. We did this by selecting the next set of TF deletion and expression profile
experiments using a novel method, PhenoProphet, which assigns a score to each TF based on the
confidence that the TF regulates a phenotype of interest. Although this method worked well,
there is a high time and monetary cost associated with generating a TF deletion strain and
expression profiling the strain. Therefore the PhenoProphet method could be improved by adding
a complete cost benefit analysis to the scoring of TFs. An improved PhenoProphet should
consider the novelty of the TF-phenotype relationship, the knowledge base of the sub-network
the TF resides in, the cost associated with generating the deletion, and the amount of deletions
that can be generated in total.
Our focus in Chapter 3 is on identifying the key transcription factors that regulate capsule
induction. However, we can also use the network to identify the non-regulator end-effector genes
that encode the enzymes and transporters necessary for capsule synthesis. In preliminary
investigations, we trained a random forest model to classify genes as capsule synthesis endeffectors based on their regulation patterns. This machine learning approach was promising, but
investigation of other machine learning classifiers, and the inclusion of additional predictive
features, such as temporal expression patterns, could improve classification accuracy.
Conservation is an important sign of functionality in DNA sequence analysis. In recent
years, with the increased availability of expression profiles and network inference methods,
transcriptional regulatory networks have been inferred for many well-studied organisms.
Although transcriptional networks exist for many organisms, these networks are rarely compared
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to identify conserved interactions among orthologous genes. A promising area of future work is
multi-species network conservation and alignment. One potential benefit of network
conservation research is strengthening network structural accuracy by modifying the confidence
in each inferred interaction based on the level of conservation of the interaction. In addition,
networks could be aligned and those alignments could then be compared to identify important
similarities and differences related to organism phenotype similarities and differences. Currently
it is possible to apply these principles of network conservation to better infer and understand the
regulatory network controlling capsule induction in Cryptococcus neoformans. In Gene
Expression Omnibus there are at least 100 expression profiles of five fungi, including the
Ascomycota phylum fungi Saccharomyces cerevisiae, Schizosaccharomyces pombe, and
Candida albicans, and the Basidiomycota phylum fungi Cryptococcus neoformans and Ustilago
maydis (Barrett et al. 2013). Transcriptional networks could be inferred for each of the five
fungi, and the network of Cryptococcus neoformans could be modified based on interaction
conservation. In addition, non-conserved interactions unique to Cryptococcus neoformans could
be studied in depth due to their potential importance for cryptococcal specific virulence.
In addition to using the network to guide experimentation, in Chapter 3, we also overlay
temporal expression patterns on the network hierarchy to generate an initial model of the
dynamics of cryptococcal capsule regulation. However, to truly understand the dynamics of
capsule regulation, we must observe the cryptococcal expression state over the course of capsule
induction and in a variety of different host-like conditions. With expression profiles in a variety
of partial and complete capsule inducing conditions, the conditions and molecular responses
required to generate capsule could be identified. Also, with large-scale expression profiling over
multiple time-points of capsule induction, the transcriptional network models specific to each
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time-point could be inferred and the time-course of specific processes required to generate
capsule could be understood.
The ultimate goal of this thesis was to develop methods which utilized the predictive power
of transcriptional regulatory network models to aid in experimental design and cellular
engineering efforts. In Chapter 4 we demonstrated that transcriptional network models are
capable of making accurate qualitative predictions of the gene expression and physiological
phenotype state in novel genotypes, which can be used to guide future research. However, the
accuracy of quantitative predictions necessary to truly understand and manipulate cellular
decision making is still lacking with current network models.
In uncompleted research work, we have developed a workflow for generating accurate
quantitative phenotype predictions for an organism in a novel genotype. We have proposed to
first generate a causative network model by integrating direct and functional evidence using the
methods presented in Chapter 2. Then we would simulate the novel genotype using the causative
network’s underlying parameterized mathematical model to generate the predicted expression
state. Next, we would take the intersection of two rounds of feature selection to limit the set of
explanatory genes used to predict the physiological phenotype. In one round of feature selection,
we would test expression prediction accuracy through cross validation on observed expression
states, and choose only the genes whose expression can be predicted reliably by the network
model. In the second round of feature selection, we would identify gene biomarkers of the
phenotype as genes whose expression pattern correlates with the measured levels of the
phenotype. After feature selection, we would use the observed gene expression profiles and
matching phenotype levels to train a supervised machine learning model, such as a random
forest, to link the expression state of the selected genes to physiological phenotype state. Finally,
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we would generate the predicted phenotype level in the novel genotype by supplying the trained
machine learning model with the predicted expression state of the selected genes in the novel
genotype. We have attempted to apply this approach to modeling and predicting the response of
Drosophila melanogaster to high and low sugar feeding, but several problems emerged that
limited the accuracy of hemolymph glucose levels, fat body triacylglyceride levels (TAG) and animal
weight phenotype predictions.
We found that the gene expression predictions were quite noisy, resulting in only a very small
fraction of genes passing both feature selection steps. In an effort to improve the novel genotype
expression predictions, we have started to improve the causative network model. Previously, we have
observed that better network models can be constructed by combining multiple network models, each
inferred from a different expression profiling dataset[CITE HAYNES ET AL 2012]. We will improve our
sugar response network model by combining network models inferred using 1,551 expression profiles
from 14 large publically available Drosophila melanogaster expression datasets. In addition, we will
integrate direct regulatory evidence, in the form of binding specificities, for an additional 72 Drosophila

melanogaster TFs. When integrated into the causative network model, 372 of the 701 modelled
TFs will have both direct and functional regulation evidence. Also, we will apply the methods
discussed in Chapter 2 to discover the binding specificity of addition TFs.
We also found that further work was required to improve the prediction of physiological
phenotypes from gene expression predictions. Due to the expected noise of gene expression
predictions it is necessary to utilize noise tolerant prediction methods, even after improvements
to the causative network model. One approach to reduce the noise inherent in the independent
variable genes used to predict phenotype would be to combine genes into pathways of genes, and
use the expression of each pathway, summarized by the mean expression of genes within each
pathway, as the independent variables. Another difficulty we encountered when predicting the
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Drosophila melanogaster phenotypes was that the gene expression and phenotype states differ
greatly between the observed high and control sugar feeding conditions. Unfortunately, neither
sugar feeding condition had enough observations of expression and phenotype level to generate a
sugar environment specific model. Therefore, a sugar independent model of phenotype level was
required, but we encountered difficulties training an accurate model of both conditions.
Specifically, due to the large differences between the sugar feeding conditions, error reduction
during model training focused on the effect of sugar feeding, rather than the more nuanced effect
of genotype. Further exploratory work is required to fix this issue, and viable methods may
include normalizing the data to remove the effect of the sugar feeding condition, or utilizing
additional feature selection to identify predictors important in both sugar feeding conditions.
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Appendix
Appendix Figure 1. PWM Inference and Integration Steps.

The steps necessary to infer and integrate PWMs into a network model are outlined
above. First, we utilize NetProphet to infer a gene regulatory network model from gene
expression profiles. Then we modify the TF-target interaction scores using each TF’s regulatory
sign and DBD homology (see 2.5.4 Improving DNA Binding Specificity Inference). FIRE is
used to infer PWMs for each TF by identifying 7-mers that occur often in the promoter
sequences of targets with high modified TF-target interaction scores. Good PWMs are selected
by comparing the PWM ranking of target genes to the expression-only network ranking of target
genes. Finally, selected PWMs are used to build a binding-based network model which is
combined with the expression-based network model.
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Appendix Table 1. Mutant strains generated in KN99α.
Gene name
ADA2
ARO8001
ASG1
ASG101
BIK1
CAC1
CCD3
CCD4
CCD6
CEP3
CIR1
CLR1
CLR2
CLR3
CLR4
CLR5
CLR6
ECM2201
FAP1
FHL1
FKH101
FKH2
GAT201
HAP2
HAP3
HAP5
HOG1
MAL13
MBS1
MCM1
MLR1
NRG1
PDR802
PKR1
RDS2
RIM101
SSN801
SWI6
TUP1
USV101
YRM103
a

Gene identifier
CNAG_01626
CNAG_04345
CNAG_03849
CNAG_03018
CNAG_06352
CNAG_03202
CNAG_00732
CNAG_03279
CNAG_06252
CNAG_06276
CNAG_04864
CNAG_04353
CNAG_03378
CNAG_00871
CNAG_04908
CNAG_05067
CNAG_07797
CNAG_00883
CNAG_07506
CNAG_05535
CNAG_05861
CNAG_02566
CNAG_01551
CNAG_07435
CNAG_02215
CNAG_07680
CNAG_01523
CNAG_02774
CNAG_07464
CNAG_07924
CNAG_00031
CNAG_05222
CNAG_03894
CNAG_00570
CNAG_03902
CNAG_05431
CNAG_00440
CNAG_01438
CNAG_02153
CNAG_05420
CNAG_04093

Selection criterion
Correlation
Correlation
Correlation
Otherb
Phenoprophet
Literature
Correlation
Correlation
Correlation
Correlation
Literature
Phenoprophet
Phenoprophet
Correlation
Correlation
Correlation
Otherd
Correlation
Correlation
Phenoprophet
Phenoprophet
Phenoprophet
Literature
Phenoprophet
Literature
Literature
Literature
Correlation
Phenoprophet
Otherd
Correlation
Literature
Phenoprophet
Literature
Correlation
Literature
Literaturee
Phenoprophet
Literature
Correlation
Correlation

Difference from wild type, in pixels.
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Capsule thicknessa
-15
1
-2
NA
-1
-29
1
-1
0
3
-18
3
0c
4
-3
-3
-4
-10
-9
-12
3
3
-21
0
-7
-9
5
-2
-12
-3
-2
-9
3
11
0
-16
0c
-3
7
3
-1

b

ASG101 was deleted for an unrelated project; it is included here because its expression profile was included as
input for our NetProphet network.
c

Strains lacking CLR2 and SSN801 have normal capsule thickness but increased variance; see text.

d

CLR6 and MCM1 were selected for deletion based on manual inspection of an early version of the network.

e

ssn801 cells were previously reported to be hypercapsular, but we find that the distribution of capsule thicknesses
for these cells has the same mean, but significantly increased variance, compared to wild type.

Appendix Table 2.A. Capsule-implicated genes not shown in Appendix Table 1 that were used
for PhenoProphet analysis.

LOCUS
CNAG_00
124
CNAG_00
268
CNAG_00
375
CNAG_00
396
CNAG_00
531

CNAG_00
600
CNAG_00
623
CNAG_00
697
CNAG_00
701

NAME

YEAST
ORF

YEAST
NAME

CAS32

YJL010C

NOP9

ILV2

YMR108W ILV2

GCN5

YGR252W GCN5

PKA1

YKL166C

TPK3

5E-125 Hypocapsular

ENA1

YDR039C

ENA2

0E+0 Hypercapsular

CAP60

YPL058C

PDR12

EGCrP1 YIR007W

YIR007W

UGE1

YBR019C

GAL10

CAS31

YGR004W PEX31

CNAG_00
721
CAP59

YBR274W CHK1

CNAG_00
746
CNAG_00
769
CNAG_00
996
CNAG_01
106

Cn Sc
PROTEIN
ALIGNMEN
T EVAL
RATIONALE
CITATION
Hypocapsular in Moyrand et al.,
5E-1 Double
2004
Kingsbury et
0E+0 Hypocapsular
al.,2004
O'Meara et
4E-112 Hypocapsular
al.,2010
Hicks et al.,2004

Jung et al., 2012
Chang and KwonChung,1998;
Moyrand and
2E+0 Hypocapsular
Janbon,2004
Ishibashi et al
1E-54 Hypocapsular
2012
Moyrand et
6E-83 Hypercapsular
al.,2007
Hypocapsular in Moyrand et al.,
2E+0 double
2004
Chang and KwonChung,1994;
Moyrand and
1E+0 Hypocapsular
Janbon,2004
Moyrand et
al.,2004; Moyrand
4E+0 Hypocapsular
et al.,2007

PMID
15590825
15133116
20581290
14871933
22343280

9573112,
15590833
22072709
17462022
15590825

8007987,
15590833
15590825,
17462022

CAS35

YHR165C

PRP8

PBS2

YJL128C

PBS2

9E-104 Hypercapsular

Bahn et al.,2005

PMT4

YJR143C

PMT4

2E-176 Hypocapsular

VPH1

YOR270C

VPH1

0E+0 Hypocapsular

Willger et al.,2009 19633715
Erickson et
al.,2001
11737651

[111]

15728721

CNAG_01
156
CNAG_01
172
CNAG_01
371
CNAG_01
654
CNAG_01
678
CNAG_01
727
CNAG_01
845
CNAG_01
890
CNAG_02
029
CNAG_02
036
CNAG_02
236
CNAG_02
581
CNAG_02
702
CNAG_02
797
CNAG_02
885
CNAG_03
120
CNAG_03
322
CNAG_03
426
CNAG_03
438
CNAG_03
582
CNAG_03
644
CNAG_03
670
CNAG_03
735
CNAG_03
818
CNAG_04
312
CNAG_04
320
CNAG_04

1E+0 Homology

Moyrand et
al.,2007

17462022

YGR099W TEL2

1E+0 Hypocapsular

Liu et al.,2007

17337638

CRG2

YOR301W RAX1

3E-10 Hypercapsular

18658258

CAS34

YOR377W ATF1

2E+0 GXM defect

Shen et al,2008
Moyrand et
al.,2007

NHA1

YLR138W NHA1

1E-122 Hypercapsular

Jung et al., 2012

22343280

SSA1

YER103W SSA4

0E+0 Hypercapsular

Zhang et al.,2006

17040492

PKC1

YBL105C

PKC1

2E-128 Hypocapsular

Heung et al.,2005

15946943

MET6

YER091C

MET6

0E+0 Hypocapsular

WSP1

YOR181W LAS17

CAS4

YML038C

PPG1

YNR032W PPG1

CAS33

YGL173C

KEM1

CLC-A

YJR040W

GEF1

CPL1

YML029W USA1

1E+0 Hypocapsular

CAP64

YGR191W HIP1

8E+0 Hypocapsular

AGS1

YGR292W MAL12

4E-5 Hypocapsular

UXS1

YBR019C

GMT2

YGL225W VRG4

HXT1

YMR011W HXT2

RIM20

YOR275C

RIM20

CAS3

YPL164C

MLH3

IRE1

YHR079C

IRE1

1E-104 Hypocapsular

CAP4

YGR286C

BIO2

1E-1 Homology

SSK1

YLR006C

SSK1

MAN1

YER003C

CPS1
GPA1

CAP2

YNL183C

PBX1

NPR1

YMD8

GAL10

17462022

Pascon et al.,2004 15347759

1E-26 Hypocapsular
Shen et al,2011
Hypocapsular in Moyrand et
9E-5 double
al.,2007

21357479

4E-104 Hypocapsular
Gerik et al.,2005
Hypocapsular in Moyrand et al.
5E-1 double
2004
Zhu and
3E-122 Hypocapsular
Williamson,2003

16194228

17462022

15590825
14622414

Liu et al.,2008
18854164
Chang et al.,1996;
Moyrand and
8675296,
Janbon,2004
15590825
Reese et al.,2007
Moyrand et
al.,2002

1E-10 Hypocapsular
Hypocapsular in
1E-89 double
Cottrell et al., 2007
Chikamori and
6E-87 Hypercapsular
Fukushima, 2005
O'Meara et
8E-26 Hypocapsular
al.,2010
Hypocapsular in Moyrand et al.
4E+0 double
2004

17244196
12139628
17351078
15907385
20174553
15590825

Cheon et al. 2011
Moyrand et al.
2007

21852949

9E-50 Hypercapsular

Bahn et al,2007

17951522

PMI40

2E-52 Hypocapsular

Wills et al.,2001

11359567

YBR023C CHS3
YER020W GPA2

1E-2 Hypocapsular
9E-112 Hypocapsular

Chang et al.,2006
Alspaugh et

16790766
9389652

[112]

17462022

505
CNAG_04
730
GPR4
CNAG_04
969
UGD1
CNAG_05
081
PDE1
CNAG_05
139
UGT1
CNAG_05
148
CXT1
CNAG_05
218
ACA1
CNAG_05
254
NSTX
CNAG_05
465
GIB2
CNAG_05
562
PBX2
CNAG_05
563
HOS2
CNAG_05
581
CNAG_05
650
CNAG_05
703
CNAG_05
721
CNAG_05
817
CNAG_06
016
CNAG_06
301
CNAG_06
591
CNAG_06
808
CNAG_06
813
CNAG_07
408
CNAG_07
470

al.,1997
YMR172W HOT1

2E-2 Hypocapsular

YDR109C

6E-1 Hypocapsular

YDR109C

YGL248W PDE1

1E-5 Hypercapsular

YER077C

YER077C

6E-1 Hypercapsular

YLR288C

MEC3

4E+0 GXM defect

Xue et al.,2006
16291861
Moyrand and
Janbon,2004;
15590833,
Griffith et al.,2004 15383535
Hicks et al.,2005
Moyrand et
al.,2007
Moyrand et
al.,2007; Klutts et
al.2007

16339715

Bahn et al.,2004
Doering et al.
unpublished

15590822

YNL138W SRV2

6E-75 Hypocapsular

YPL244C

6E-41 Hypocapsular
overexpression
suppresses gpa11E-92 capsule defect
Palmer,et al 2006

HUT1

YMR116C ASC1
YGR125W YGR125W

2E-1 Hypocapsular

17462022
17462022
,17430900

16950773

Liu et al.,2007

17337638

Liu et al.,2008
Baker et
al.,2007,Banks et
al.,2005

18854164

YGL194C

HOS2

3E-137 Hypercapsular

CHS3

YBR023C

CHS3

0E+0 Hypercapsular

UBP5

YMR304W UBP15

8E-160 Hypocapsular

Fang et al.,2012

22719877

LRG1

YDL240W LRG1

7E-61 Hypocapsular

16194228

MFE2

YKR009C

FOX2

0E+0 Hypocapsular

Gerik et al.,2005
Kretschmer et
al.,2012

GMT1

YGL225W VRG4

2E-92 Hypocapsular

CAP6

YIR021W

SCH9

YHR205W SCH9

SET302

YKR029C

SET3

CPRa

YKL178C

CAP1

YML128C

STE20

YNL298W CLA4

PDE2

YOR360C

CNAG_07
554
CAP10

MRS1

6E-1 Homology

22707485

Cottrell et al.,2007 17351078
Moyrand et
al.,2007
17462022
Wang et al.,2004

15503029

7E-21 Hypercapsular

Liu et al.,2008

18854164

STE3

2E-24 Hypocapsular

12933837

MSC1

2E+0 Homology

Chang et al.,2003
Lengeler et
al.,2002

1E-113 Hypocapsular

Wang et al.,2002

12455960

PDE2

YOR172W YRM1

2E-142 Hypercapsular

17400891,
16278457

2E-21 Hypercapsular

4E+0 Hypocapsular

[113]

12455690

Hicks et al.,2005 16339715
Chang and KwonChung,1999;
Moyrand and
10482503,
Janbon,2004
15590825

CNAG_07
636
CNAG_07
701
CNAG_07
718
CNAG_07
937

CSR2

YBL061C

SKT5

3E-73 Hypercapsular

CTR2

YLR411W CTR3

5E-1 Hypocapsular

CIN1

YIR006C

CAS1

YGL139W FLC3

PAN1

2E-33 Hypocapsular
O-acetylation
5E+0 defect

Baker et
al.,2007,Banks et
al.,2005
Chun and
Madhani, 2010
Shen et al,2010

17400891,
16278457
20824073
20345666

Janbon et al.,2001 17462022

Appendix Table 2.B. Regulator genes used for methods analysis in Fig. 3.4, with closest yeast
homolog, protein alignment Eval, TF status (DNA-binding TF or not), capsule phenotype, and
source for the phenotype; blue shading indicates genes that were not part of our uniform deletion
set in KN99.

LOCUS
CNAG_0
0031
CNAG_0
0156
CNAG_0
0193

CNAG_0
0440
CNAG_0
0570
CNAG_0
0732
CNAG_0
0871
CNAG_0
0883
CNAG_0
1242
CNAG_0
1438
CNAG_0
1454
CNAG_0
1523
CNAG_0

Cn Sc
PROTEIN
ALIGNMENT
EVAL
IS TF

NAME

YEAST
ORF

YEAST
NAME

MLR1

YLR014C

PPR1

SP1

YNL027W CRZ1

GAT1

YFL021W

GAT1

SSN801

YNL025C

SSN8

PKR1

YIL033C

BCY1

CCD3

YML076C

WAR1

1E-1 TRUE Normal

CLR3

YFL031W

HAC1

2E+0 TRUE Hypercapsular This study

ECM2201 YLR228C

ECM22

9E-5 TRUE Hypocapsular

HAPX

YDR259C

YAP6

3E-4 TRUE Normal

SWI6
STE12α

YLR182W SWI6
YHR084W STE12

HOG1
GAT201

YLR113W HOG1
YMR136W GAT2

CAPSULE
EVIDENCE

SOURCE

This study
Adler et al,
2E-23 TRUE Hypercapsular 2011
Kmetzsch et
2E-21 TRUE DefectInGXM al. 2011
Liu et
al.,2008;
found to be
hypervarible
5E-24 FALSE Hypervariable in this study
D'Souza et
5E-61 FALSE Hypercapsular al.,2001

PMID

2E-27 TRUE Normal

21487010
20673806

18854164
11287622

This study

This study
Jung et al.
2010

This study
Yue et al.
7E-31 TRUE Hypocapsular 1999
Bahn et
4E-172 FALSE Hypercapsular al.,2005
4E-13 TRUE Hypocapsular Liu et

21124817

1E-40 TRUE Hypocapsular

[114]

10581270
15728721
18854164

1551
CNAG_0
1626
ADA2
CNAG_0
2153
TUP1
CNAG_0
2215
HAP3
CNAG_0
2435
CNAG_0
2566
CNAG_0
2774
CNAG_0
3202
CNAG_0
3279
CNAG_0
3366
CNAG_0
3378
CNAG_0
3409
CNAG_0
3849
CNAG_0
3894
CNAG_0
3902
CNAG_0
4093
CNAG_0
4345
CNAG_0
4353
CNAG_0
4864
CNAG_0
4908
CNAG_0
5067
CNAG_0
5222
CNAG_0
5392
CNAG_0
5420
CNAG_0
5431
CNAG_0
5535

YDR448W ADA2
YCR084C

TUP1

YBL021C

HAP3

al.,2008
Haynes et al.
2E-74 TRUE Hypocapsular 2011
Lee et
1E-102 FALSE Hypercapsular al,2009
Jung et. al
5E-41 TRUE Hypocapsular 2010
Idnurm et al.
2005; Lu et
2E-11 TRUE Normal
al. 2005

22174677
19820119
21124817

CWC2/
BWC2

YMR136W GAT2

FKH2

YNL068C

MAL13

YKL038W RGT1

6E-8 TRUE Normal

CAC1

YJL005W

0E+0 FALSE Hypocapsular

CCD4

YDR213W UPC2

7E-7 TRUE Normal

ZNF2

YNL027W CRZ1

1E-14 TRUE Normal

CLR2

YLR399C

1E+0 FALSE Hypervariable

SKN7

YHR206W SKN7

6E-30 TRUE Normal

ASG1

YIL130W

3E-18 TRUE Normal

PDR802

YLR256W HAP1

RDS2

YPL133C

RDS2

6E-49 TRUE Normal

This study

YRM103

YLR014C

PPR1

5E-7 TRUE Normal

This study

ARO8001

YDR421W ARO80

6E-6 TRUE Normal

This study

CLR1

YJR127C

RSF2

CIR1

YJL110C

GZF3

CLR4

YGR089W NNF2

9E-1 TRUE Hypocapsular

This study

CLR5

YLR399C

BDF1

6E-1 FALSE Hypocapsular

NRG1

YDR043C

NRG1

2E-17 TRUE Hypocapsular

ZAP104

YJL056C

ZAP1

7E-39 TRUE Normal

This study
Cramer et
al.,2006
16835458
Schneider et
al. 2012
22916306

USV101

YPL230W

USV1

RIM101

YHL027W RIM101

5E-19 TRUE Hypercapsular This study
O'Meara et
5E-32 TRUE Hypocapsular al.,2010

FHL1

YPR104C

4E-16 TRUE Hypocapsular

FKH2

CYR1

BDF1

ASG1

FHL1

15760278,
15813738

2E-15 TRUE Hypercapsular This study
This study
Alspaugh et
al.,2002

12455973

This study
Lin et al.
2010

20485569

This study
Coenjaerts et
al. 2006
16696662

This study
This study; called normal
capsular by Liu et al,
4E-8 TRUE Hypercapsular 2008

2E-2 TRUE Hypercapsular This study
Jung et
8E-18 TRUE Hypocapsular al.,2006

[115]

This study

17121456

20174553

CNAG_0
5861
CNAG_0
6134
CNAG_0
6252
CNAG_0
6276
CNAG_0
6352
CNAG_0
6762
CNAG_0
7435
CNAG_0
7464
CNAG_0
7506
CNAG_0
7680
CNAG_0
7797
CNAG_0
7924

FKH101

YIL131C

FKH1

BZP1

YFL031W

HAC1

CCD6

YDR213W UPC2

8E-8 TRUE Normal

CEP3

YMR168C CEP3

1E-6 TRUE Hypercapsular This study

BIK1

YCL029C

BIK1

1E-7 FALSE Normal

GAT204

YMR136W GAT2

3E-6 TRUE Normal

HAP2

YGL237C

MBS1

YDL056W MBP1

7E-36 TRUE Hypocapsular

FAP1

YNL023C

FAP1

8E-23 TRUE Hypocapsular

HAP5

YOR358W HAP5

CLR6

YKL070W YKL070W

MCM1

YMR043W MCM1

HAP2

2E-9 TRUE Hypercapsular This study
Idnurm et al.
8E-2 TRUE Normal
2009
19151325
This study

This study
Chun et al.
2011

21402362

This study
Song et al,
2012

22080454

2E-35 FALSE Hypocapsular

This study
Jung et
al,2010

21124817

3E-8 FALSE Hypocapsular

This study

6E-34 TRUE Hypocapsular

This study

2E-24 FALSE Normal

[116]

